Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Visit

100 day 6 months 1 year 2 years > 2 years

Specify:

Vital Status Questions: 1 - 9

Date of actual contact with the patient to determine the medical status for this follow-up report:1 __ __ __ __ - __ __- __ __

Specify the patient's survival status at the date of last contact

Alive Dead

2

Primary cause of death3

Specify:4

What scale was used to determine the patient’s functional status?

Karnofsky Lansky

5

Karnofsky scale (patient age ≥ 16 years)6

Lansky scale (patient age < 16 years)7

Has the patient become pregnant since the date of last report? (Female only)

Yes No Unknown

8

Has the patient fathered any children since the date of last report? (i.e. contributed to any pregnancies) (Male only)

Yes No Unknown

9

Organ Function Questions: 10 - 39

AST (SGOT)

Known Unknown

10

11 U/L µkat/L

Date sample collected:12 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:13 U/L µkat/L

ALT (SGPT)

Known Unknown

14

15 U/L µkat/L

Date sample collected:16 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:17 U/L µkat/L

Total serum bilirubin

Known Unknown

18

19 mg/dL µmol/L

Date sample collected:20 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:21 mg/dL µmol/L

Serum creatinine

Known Unknown

22

23 mg/dL mmol/L µmol/L

Date sample collected:24 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:25 mg/dL mmol/L µmol/L

Serum albumin

Known Unknown

26

27 g/dL g/L

Date sample collected:28 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:29 g/dL g/L

Amylase

Known Unknown

30

31 U/L

International normalized ratio (INR)

Known Unknown

32

(INR)

33

Partial thromboplastin time (PTT)

Known Unknown

34

35 seconds

Reticulocytes

Known Unknown

36

(uncorrected)

37
x 109/L

Was a bone marrow examination performed?

yes no Unknown

38

Date sample collected:39 __ __ __ __ - __ __- __ __

Complete Blood Count Questions: 40 - 56

Was a complete blood count done since the date of last report?

Yes No

40

Date sample collected:41 __ __ __ __ - __ __- __ __

WBC

Known Unknown

42

43 x 109/L (x 103/mm3)

x 106/L

Was G­CSF given ≤ 7 days before date of test?

Yes No

44

Neutrophils

Known Unknown

45

46 %

Lymphocytes

Known Unknown

47

48 %

Hemoglobin

Known Unknown

49

50 g/dL g/L mmol/L

Was RBC transfused < 30 days before date of test?

yes no

51

Hematocrit

Known Unknown

52

53 %

Platelets

Known Unknown

54

55 x 109/L (x 103/mm3)

x 106/L

Were platelets transfused ≤ 7 days before date of test?

Yes No

56

Lymphocyte Analyses Questions: 57 - 70

Were lymphocyte analyses performed?

yes no

57

Date sample collected:58 __ __ __ __ - __ __- __ __

CD3 (T cells)

Known Unknown

59

60 x 109/L (x 103/mm3)

x 106/L

CD4 (T helper cells)

Known Unknown

61

62 x 109/L (x 103/mm3)

x 106/L

CD8 (cytotoxic T cells)

Known Unknown

63

64 x 109/L (x 103/mm3)

x 106/L

CD19

Known Unknown

65

66 x 109/L (x 103/mm3)

x 106/L

CD20 (B lymphocyte cells)

Known Unknown

67

68 x 109/L (x 103/mm3)

x 106/L

CD56 (natural killer (NK) cells)

Known Unknown

69

70 x 109/L (x 103/mm3)

x 106/L

Organ Impairment / Disorders Questions: 71 - 167

Has the patient developed any clinically significant organ impairment or disorder since the date of the last report?

Yes No

71

Chronic kidney disease / renal impairment (persistent decrease in glomerular filtration rate to < 60 ml/min/1.73m2)

Yes No

72

Date of diagnosis:73 __ __ __ __ - __ __- __ __

Serum creatinine

Known Unknown

74

(peak in reporting period)

75 mg/dL mmol/L µmol/L

Date sample collected:76 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

77

(GFR) (calculated) (peak in reporting period)

78 mL/min/1.732

Date sample collected:79 __ __ __ __ - __ __- __ __

Was a renal biopsy performed?

Yes No Unknown

80

Serum creatinine

Known Unknown

81

(lowest in reporting period)

82 mg/dL mmol/L µmol/L

Date sample collected:83 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

84

(GFR) (calculated) (peak in reporting period)

85 mL/min/1.732

Date sample collected:86 __ __ __ __ - __ __- __ __

Hemorrhagic cystitis/hematuria

Yes No

87

Date of diagnosis:88 __ __ __ __ - __ __- __ __

Renal failure requiring dialysis

Yes No

89

Date dialysis started:90 __ __ __ __ - __ __- __ __

Arrhythmia

Yes No

91

(atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmia)

Date of diagnosis:92 __ __ __ __ - __ __- __ __

Congestive heart failure / Cardiomyopathy

Yes No

93

(EF < 40%)

Date of diagnosis:94 __ __ __ __ - __ __- __ __

Specify ejection fraction:95 %

Hypertension requiring therapy

Yes No

96

Date of diagnosis:97 __ __ __ __ - __ __- __ __

Myocardial infarction / Unstable angina

Yes No

98

Date of diagnosis:99 __ __ __ __ - __ __- __ __

Pericarditis

Yes No

100

Date of diagnosis:101 __ __ __ __ - __ __- __ __

Deep vein thrombosis (DVT) / Pulmonary embolism (PE)

Yes No

102

Date of diagnosis:103 __ __ __ __ - __ __- __ __

Was the DVT catheter related?

Yes No

104

Thrombotic microangiopathy

Yes No

105

(TMA)

Date of diagnosis:106 __ __ __ __ - __ __- __ __

CNS hemorrhage

Yes No

107

Date of diagnosis:108 __ __ __ __ - __ __- __ __

Encephalopathy

Yes No

109

(non-infectious)

Date of diagnosis:110 __ __ __ __ - __ __- __ __

Neuropathy

Yes No

111

Date of diagnosis:112 __ __ __ __ - __ __- __ __

Seizures

yes no

113

Date of diagnosis:114 __ __ __ __ - __ __- __ __

Stroke

Yes No

115

Date of diagnosis:116 __ __ __ __ - __ __- __ __

Transient ischemic attack

Yes No

117

(TIA)

Date of diagnosis:118 __ __ __ __ - __ __- __ __

Diabetes / hyperglycemia (requiring chronic treatment)

Yes No

119

Date of diagnosis:120 __ __ __ __ - __ __- __ __

Growth hormone deficiency / growth disturbance

Yes No

121

Date of diagnosis:122 __ __ __ __ - __ __- __ __

Hypothyroidism (requiring replacement therapy)

Yes No

123

Date of diagnosis:124 __ __ __ __ - __ __- __ __

Pancreatitis

Yes No

125

Date of diagnosis:126 __ __ __ __ - __ __- __ __

Diarrhea requiring therapy (requiring chronic treatment)

Yes No

127

Date of diagnosis:128 __ __ __ __ - __ __- __ __

Gastrointestinal (GI) bleeding

Yes No

129

Date of diagnosis:130 __ __ __ __ - __ __- __ __

Gonadal dysfunction / infertility requiring hormone replacement (testosterone or estrogen)

Yes No

131

Date of diagnosis:132 __ __ __ __ - __ __- __ __

Cirrhosis

Yes No

133

Date of diagnosis:134 __ __ __ __ - __ __- __ __

VOD

Yes No

135

Date of diagnosis:136 __ __ __ __ - __ __- __ __

Other non-infectious liver toxicity

Yes No

137

Date of diagnosis:138 __ __ __ __ - __ __- __ __

Avascular necrosis

Yes No

139

Date of diagnosis:140 __ __ __ __ - __ __- __ __

Osteoporosis

Yes No

141

Date of diagnosis:142 __ __ __ __ - __ __- __ __

Depression requiring therapy

Yes No

143

Date of diagnosis:144 __ __ __ __ - __ __- __ __

Anxiety requiring therapy

Yes No

145

Date of diagnosis:146 __ __ __ __ - __ __- __ __

Post-traumatic stress disorder (PTSD) requiring therapy

Yes No

147

Date of diagnosis:148 __ __ __ __ - __ __- __ __

Bronchiolitis obliterans

Yes No

149

Date of diagnosis:150 __ __ __ __ - __ __- __ __

Cryptogenic organizing pneumonia

Yes No

151

(COP/BOOP)

Date of diagnosis:152 __ __ __ __ - __ __- __ __

Fibrosis

Yes No

153

Date of diagnosis:154 __ __ __ __ - __ __- __ __

Interstitial pneumonitis (IPn) / ARDS

Yes No

155

Date of diagnosis:156 __ __ __ __ - __ __- __ __

Pulmonary or diffuse alveolar hemorrhage

Yes No

157

Date of diagnosis:158 __ __ __ __ - __ __- __ __

Strictures (related to exposure)

Yes No

159

Date of diagnosis:160 __ __ __ __ - __ __- __ __

Wounds requiring surgery (related to exposure)

Yes No

161

Date of diagnosis:162 __ __ __ __ - __ __- __ __

Cataracts

Yes No

163

Date of diagnosis:164 __ __ __ __ - __ __- __ __

Other impairment or disorder

Yes No

165

Date of diagnosis:166 __ __ __ __ - __ __- __ __

Specify other impairment / disorder:167

New Malignancy Questions: 168 - 212

Did a new malignancy, myelodysplastic, or myeloproliferative disorder appear since the date of last report?

Yes No

168

Acute myeloid leukemia (AML / ANLL)

yes no

169

Date of diagnosis:170 __ __ __ __ - __ __- __ __

Other leukemia, including ALL

yes no

171

Date of diagnosis:172 __ __ __ __ - __ __- __ __

Specify other leukemia:173

Breast cancer

yes no

174

Date of diagnosis:175 __ __ __ __ - __ __- __ __

Central nervous system (CNS) malignancy

Yes No

176

(e.g. glioblastoma, astrocytoma)

Date of diagnosis:177 __ __ __ __ - __ __- __ __

Clonal cytogenetic abnormality without leukemia or MDS

Yes No

178

Date of diagnosis:179 __ __ __ __ - __ __- __ __

Gastrointestinal malignancy

Yes No

180

(e.g. colon, rectum, stomach, pancreas, intestine)

Date of diagnosis:181 __ __ __ __ - __ __- __ __

Genitourinary malignancy

Yes No

182

(e.g. kidney, bladder, ovary, testicle, genitalia, uterus, cervix)

Date of diagnosis:183 __ __ __ __ - __ __- __ __

Lung cancer

yes no

184

Date of diagnosis:185 __ __ __ __ - __ __- __ __

Hodgkin disease

yes no

186

Date of diagnosis:187 __ __ __ __ - __ __- __ __

Lymphoma or lymphoproliferative disease

Yes No

188

Date of diagnosis:189 __ __ __ __ - __ __- __ __

Was the tumor EBV positive?

yes no

190

Melanoma

Yes No

191

Date of diagnosis:192 __ __ __ __ - __ __- __ __

Basal cell skin malignancy

Yes No

193

Date of diagnosis:194 __ __ __ __ - __ __- __ __

Squamous cell skin malignancy

Yes No

195

Date of diagnosis:196 __ __ __ __ - __ __- __ __

Myelodysplastic syndrome (MDS)

yes no

197

Date of diagnosis:198 __ __ __ __ - __ __- __ __

Myeloproliferative neoplasm (MPN)

yes no

199

Date of diagnosis:200 __ __ __ __ - __ __- __ __

Myelodysplasia / myeloproliferative neoplasm

Yes No

201

Date of diagnosis:202 __ __ __ __ - __ __- __ __

Oropharyngeal cancer (e.g. tongue, buccal mucosa)

Yes No

203

Date of diagnosis:204 __ __ __ __ - __ __- __ __

Sarcoma

Yes No

205

Date of diagnosis:206 __ __ __ __ - __ __- __ __

Thyroid cancer

yes no

207

Date of diagnosis:208 __ __ __ __ - __ __- __ __

Other new malignancy

yes no

209

Date of diagnosis:210 __ __ __ __ - __ __- __ __

Specify other new malignancy:211

Was documentation submitted to the CIBMTR? (e.g. pathology/autopsy report or other documentation)

Yes No

212

Infection Questions: 213 - 219

Did the patient develop a clinically significant infection since the date of last report?

Yes No

213

Infection (1) Questions: 214 - 219

Organism:214

Specify other organism:215

Site:216

Site:217

Site:218

Date of diagnosis:219 __ __ __ __ - __ __- __ __

Therapy Questions: 220 - 258

Was therapy given since the date of last report?

yes no

220

Systemic antibacterial antibiotics

Yes No Unknown

221

Non-absorbable oral antibiotics

Yes No Unknown

222

Systemic antifungal drugs

Yes No Unknown

223

Amphotericin

Yes No

224

(Fungizone) (non-lipid formulation)

Amphotericin

Yes No

225

(e.g. Abelcet, AmBisome, Amphotec) (lipid formulation)

Caspofungin

Yes No

226

Fluconazole

Yes No

227

Isavuconazole

Yes No

228

Itraconazole

Yes No

229

Micafungin

Yes No

230

Posaconazole

Yes No

231

Ravuconazole

Yes No

232

Voriconazole

Yes No

233

Other systemic antifungal drug

Yes No

234

Specify other systemic antifungal drug:235

Antiviral drugs

Yes No Unknown

236

Acyclovir

yes no

237

Foscarnet

Yes No

238

Ganciclovir (DHPG)

yes no

239

Valganciclovir

Yes No

240

(Valcyte)

Valacyclovir

Yes No

241

Other antiviral drug

Yes No

242

Specify other antiviral drug:243

Growth factors

Yes No Unknown

244

G-CSF

yes no

245

GM-CSF

yes no

246

Pegylated G-CSF

yes no

247

TBO-filgrastim

Yes No

248

Other growth factor

yes no

249

Specify other growth factor:250

Corticosteroids

yes no

251

Erythropoietin

yes no

252

RBC transfusion

Yes No

253

Platelet transfusion

Yes No

254

HCT

Yes No

255

Cellular therapy

yes no

256

Other therapy

yes no

257

Specify other therapy:258

First Name: Last Name:

E-mail address: Date: __ __ __ __ - __ __- __ __

Specify the patient's functional status at last contact:

Provide the most recent value for each lab tested since the date of last report:

Report the most recent complete blood count:

Report the most recent lab values:

Other Organ Impairment/Disorder

Specify impairment/disorder:

Renal

Report highest values measured in this reporting period:

Report the lowest values measured in this reporting period:

Cardiac

Vascular

Central nervous system

Endocrine

Gastrointestinal

Genitourinary

Liver Toxicity

Musculoskeletal

Psychiatric

Pulmonary

Skin

Other

Specify which new disease(s) occurred:

Report each infection organism, site and date of diagnosis:

Do not report fever in the absence of infection.  Report the most specific site of infection. 

Specify therapy given for exposure or complications from exposure, since the date of last report:

Specify therapy given:

Center: CRID: 

Form 5001 R1.0: RITN Follow-Up Form

CIBMTR Form 5001 revision 1.0 last updated Monday, December 21, 2015
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 1 / 8



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Visit

100 day 6 months 1 year 2 years > 2 years

Specify:

Vital Status Questions: 1 - 9

Date of actual contact with the patient to determine the medical status for this follow-up report:1 __ __ __ __ - __ __- __ __

Specify the patient's survival status at the date of last contact

Alive Dead

2

Primary cause of death3

Specify:4

What scale was used to determine the patient’s functional status?

Karnofsky Lansky

5

Karnofsky scale (patient age ≥ 16 years)6

Lansky scale (patient age < 16 years)7

Has the patient become pregnant since the date of last report? (Female only)

Yes No Unknown

8

Has the patient fathered any children since the date of last report? (i.e. contributed to any pregnancies) (Male only)

Yes No Unknown

9

Organ Function Questions: 10 - 39

AST (SGOT)

Known Unknown

10

11 U/L µkat/L

Date sample collected:12 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:13 U/L µkat/L

ALT (SGPT)

Known Unknown

14

15 U/L µkat/L

Date sample collected:16 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:17 U/L µkat/L

Total serum bilirubin

Known Unknown

18

19 mg/dL µmol/L

Date sample collected:20 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:21 mg/dL µmol/L

Serum creatinine

Known Unknown

22

23 mg/dL mmol/L µmol/L

Date sample collected:24 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:25 mg/dL mmol/L µmol/L

Serum albumin

Known Unknown

26

27 g/dL g/L

Date sample collected:28 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:29 g/dL g/L

Amylase

Known Unknown

30

31 U/L

International normalized ratio (INR)

Known Unknown

32

(INR)

33

Partial thromboplastin time (PTT)

Known Unknown

34

35 seconds

Reticulocytes

Known Unknown

36

(uncorrected)

37
x 109/L

Was a bone marrow examination performed?

yes no Unknown

38

Date sample collected:39 __ __ __ __ - __ __- __ __

Complete Blood Count Questions: 40 - 56

Was a complete blood count done since the date of last report?

Yes No

40

Date sample collected:41 __ __ __ __ - __ __- __ __

WBC

Known Unknown

42

43 x 109/L (x 103/mm3)

x 106/L

Was G­CSF given ≤ 7 days before date of test?

Yes No

44

Neutrophils

Known Unknown

45

46 %

Lymphocytes

Known Unknown

47

48 %

Hemoglobin

Known Unknown

49

50 g/dL g/L mmol/L

Was RBC transfused < 30 days before date of test?

yes no

51

Hematocrit

Known Unknown

52

53 %

Platelets

Known Unknown

54

55 x 109/L (x 103/mm3)

x 106/L

Were platelets transfused ≤ 7 days before date of test?

Yes No

56

Lymphocyte Analyses Questions: 57 - 70

Were lymphocyte analyses performed?

yes no

57

Date sample collected:58 __ __ __ __ - __ __- __ __

CD3 (T cells)

Known Unknown

59

60 x 109/L (x 103/mm3)

x 106/L

CD4 (T helper cells)

Known Unknown

61

62 x 109/L (x 103/mm3)

x 106/L

CD8 (cytotoxic T cells)

Known Unknown

63

64 x 109/L (x 103/mm3)

x 106/L

CD19

Known Unknown

65

66 x 109/L (x 103/mm3)

x 106/L

CD20 (B lymphocyte cells)

Known Unknown

67

68 x 109/L (x 103/mm3)

x 106/L

CD56 (natural killer (NK) cells)

Known Unknown

69

70 x 109/L (x 103/mm3)

x 106/L

Organ Impairment / Disorders Questions: 71 - 167

Has the patient developed any clinically significant organ impairment or disorder since the date of the last report?

Yes No

71

Chronic kidney disease / renal impairment (persistent decrease in glomerular filtration rate to < 60 ml/min/1.73m2)

Yes No

72

Date of diagnosis:73 __ __ __ __ - __ __- __ __

Serum creatinine

Known Unknown

74

(peak in reporting period)

75 mg/dL mmol/L µmol/L

Date sample collected:76 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

77

(GFR) (calculated) (peak in reporting period)

78 mL/min/1.732

Date sample collected:79 __ __ __ __ - __ __- __ __

Was a renal biopsy performed?

Yes No Unknown

80

Serum creatinine

Known Unknown

81

(lowest in reporting period)

82 mg/dL mmol/L µmol/L

Date sample collected:83 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

84

(GFR) (calculated) (peak in reporting period)

85 mL/min/1.732

Date sample collected:86 __ __ __ __ - __ __- __ __

Hemorrhagic cystitis/hematuria

Yes No

87

Date of diagnosis:88 __ __ __ __ - __ __- __ __

Renal failure requiring dialysis

Yes No

89

Date dialysis started:90 __ __ __ __ - __ __- __ __

Arrhythmia

Yes No

91

(atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmia)

Date of diagnosis:92 __ __ __ __ - __ __- __ __

Congestive heart failure / Cardiomyopathy

Yes No

93

(EF < 40%)

Date of diagnosis:94 __ __ __ __ - __ __- __ __

Specify ejection fraction:95 %

Hypertension requiring therapy

Yes No

96

Date of diagnosis:97 __ __ __ __ - __ __- __ __

Myocardial infarction / Unstable angina

Yes No

98

Date of diagnosis:99 __ __ __ __ - __ __- __ __

Pericarditis

Yes No

100

Date of diagnosis:101 __ __ __ __ - __ __- __ __

Deep vein thrombosis (DVT) / Pulmonary embolism (PE)

Yes No

102

Date of diagnosis:103 __ __ __ __ - __ __- __ __

Was the DVT catheter related?

Yes No

104

Thrombotic microangiopathy

Yes No

105

(TMA)

Date of diagnosis:106 __ __ __ __ - __ __- __ __

CNS hemorrhage

Yes No

107

Date of diagnosis:108 __ __ __ __ - __ __- __ __

Encephalopathy

Yes No

109

(non-infectious)

Date of diagnosis:110 __ __ __ __ - __ __- __ __

Neuropathy

Yes No

111

Date of diagnosis:112 __ __ __ __ - __ __- __ __

Seizures

yes no

113

Date of diagnosis:114 __ __ __ __ - __ __- __ __

Stroke

Yes No

115

Date of diagnosis:116 __ __ __ __ - __ __- __ __

Transient ischemic attack

Yes No

117

(TIA)

Date of diagnosis:118 __ __ __ __ - __ __- __ __

Diabetes / hyperglycemia (requiring chronic treatment)

Yes No

119

Date of diagnosis:120 __ __ __ __ - __ __- __ __

Growth hormone deficiency / growth disturbance

Yes No

121

Date of diagnosis:122 __ __ __ __ - __ __- __ __

Hypothyroidism (requiring replacement therapy)

Yes No

123

Date of diagnosis:124 __ __ __ __ - __ __- __ __

Pancreatitis

Yes No

125

Date of diagnosis:126 __ __ __ __ - __ __- __ __

Diarrhea requiring therapy (requiring chronic treatment)

Yes No

127

Date of diagnosis:128 __ __ __ __ - __ __- __ __

Gastrointestinal (GI) bleeding

Yes No

129

Date of diagnosis:130 __ __ __ __ - __ __- __ __

Gonadal dysfunction / infertility requiring hormone replacement (testosterone or estrogen)

Yes No

131

Date of diagnosis:132 __ __ __ __ - __ __- __ __

Cirrhosis

Yes No

133

Date of diagnosis:134 __ __ __ __ - __ __- __ __

VOD

Yes No

135

Date of diagnosis:136 __ __ __ __ - __ __- __ __

Other non-infectious liver toxicity

Yes No

137

Date of diagnosis:138 __ __ __ __ - __ __- __ __

Avascular necrosis

Yes No

139

Date of diagnosis:140 __ __ __ __ - __ __- __ __

Osteoporosis

Yes No

141

Date of diagnosis:142 __ __ __ __ - __ __- __ __

Depression requiring therapy

Yes No

143

Date of diagnosis:144 __ __ __ __ - __ __- __ __

Anxiety requiring therapy

Yes No

145

Date of diagnosis:146 __ __ __ __ - __ __- __ __

Post-traumatic stress disorder (PTSD) requiring therapy

Yes No

147

Date of diagnosis:148 __ __ __ __ - __ __- __ __

Bronchiolitis obliterans

Yes No

149

Date of diagnosis:150 __ __ __ __ - __ __- __ __

Cryptogenic organizing pneumonia

Yes No

151

(COP/BOOP)

Date of diagnosis:152 __ __ __ __ - __ __- __ __

Fibrosis

Yes No

153

Date of diagnosis:154 __ __ __ __ - __ __- __ __

Interstitial pneumonitis (IPn) / ARDS

Yes No

155

Date of diagnosis:156 __ __ __ __ - __ __- __ __

Pulmonary or diffuse alveolar hemorrhage

Yes No

157

Date of diagnosis:158 __ __ __ __ - __ __- __ __

Strictures (related to exposure)

Yes No

159

Date of diagnosis:160 __ __ __ __ - __ __- __ __

Wounds requiring surgery (related to exposure)

Yes No

161

Date of diagnosis:162 __ __ __ __ - __ __- __ __

Cataracts

Yes No

163

Date of diagnosis:164 __ __ __ __ - __ __- __ __

Other impairment or disorder

Yes No

165

Date of diagnosis:166 __ __ __ __ - __ __- __ __

Specify other impairment / disorder:167

New Malignancy Questions: 168 - 212

Did a new malignancy, myelodysplastic, or myeloproliferative disorder appear since the date of last report?

Yes No

168

Acute myeloid leukemia (AML / ANLL)

yes no

169

Date of diagnosis:170 __ __ __ __ - __ __- __ __

Other leukemia, including ALL

yes no

171

Date of diagnosis:172 __ __ __ __ - __ __- __ __

Specify other leukemia:173

Breast cancer

yes no

174

Date of diagnosis:175 __ __ __ __ - __ __- __ __

Central nervous system (CNS) malignancy

Yes No

176

(e.g. glioblastoma, astrocytoma)

Date of diagnosis:177 __ __ __ __ - __ __- __ __

Clonal cytogenetic abnormality without leukemia or MDS

Yes No

178

Date of diagnosis:179 __ __ __ __ - __ __- __ __

Gastrointestinal malignancy

Yes No

180

(e.g. colon, rectum, stomach, pancreas, intestine)

Date of diagnosis:181 __ __ __ __ - __ __- __ __

Genitourinary malignancy

Yes No

182

(e.g. kidney, bladder, ovary, testicle, genitalia, uterus, cervix)

Date of diagnosis:183 __ __ __ __ - __ __- __ __

Lung cancer

yes no

184

Date of diagnosis:185 __ __ __ __ - __ __- __ __

Hodgkin disease

yes no

186

Date of diagnosis:187 __ __ __ __ - __ __- __ __

Lymphoma or lymphoproliferative disease

Yes No

188

Date of diagnosis:189 __ __ __ __ - __ __- __ __

Was the tumor EBV positive?

yes no

190

Melanoma

Yes No

191

Date of diagnosis:192 __ __ __ __ - __ __- __ __

Basal cell skin malignancy

Yes No

193

Date of diagnosis:194 __ __ __ __ - __ __- __ __

Squamous cell skin malignancy

Yes No

195

Date of diagnosis:196 __ __ __ __ - __ __- __ __

Myelodysplastic syndrome (MDS)

yes no

197

Date of diagnosis:198 __ __ __ __ - __ __- __ __

Myeloproliferative neoplasm (MPN)

yes no

199

Date of diagnosis:200 __ __ __ __ - __ __- __ __

Myelodysplasia / myeloproliferative neoplasm

Yes No

201

Date of diagnosis:202 __ __ __ __ - __ __- __ __

Oropharyngeal cancer (e.g. tongue, buccal mucosa)

Yes No

203

Date of diagnosis:204 __ __ __ __ - __ __- __ __

Sarcoma

Yes No

205

Date of diagnosis:206 __ __ __ __ - __ __- __ __

Thyroid cancer

yes no

207

Date of diagnosis:208 __ __ __ __ - __ __- __ __

Other new malignancy

yes no

209

Date of diagnosis:210 __ __ __ __ - __ __- __ __

Specify other new malignancy:211

Was documentation submitted to the CIBMTR? (e.g. pathology/autopsy report or other documentation)

Yes No

212

Infection Questions: 213 - 219

Did the patient develop a clinically significant infection since the date of last report?

Yes No

213

Infection (1) Questions: 214 - 219

Organism:214

Specify other organism:215

Site:216

Site:217

Site:218

Date of diagnosis:219 __ __ __ __ - __ __- __ __

Therapy Questions: 220 - 258

Was therapy given since the date of last report?

yes no

220

Systemic antibacterial antibiotics

Yes No Unknown

221

Non-absorbable oral antibiotics

Yes No Unknown

222

Systemic antifungal drugs

Yes No Unknown

223

Amphotericin

Yes No

224

(Fungizone) (non-lipid formulation)

Amphotericin

Yes No

225

(e.g. Abelcet, AmBisome, Amphotec) (lipid formulation)

Caspofungin

Yes No

226

Fluconazole

Yes No

227

Isavuconazole

Yes No

228

Itraconazole

Yes No

229

Micafungin

Yes No

230

Posaconazole

Yes No

231

Ravuconazole

Yes No

232

Voriconazole

Yes No

233

Other systemic antifungal drug

Yes No

234

Specify other systemic antifungal drug:235

Antiviral drugs

Yes No Unknown

236

Acyclovir

yes no

237

Foscarnet

Yes No

238

Ganciclovir (DHPG)

yes no

239

Valganciclovir

Yes No

240

(Valcyte)

Valacyclovir

Yes No

241

Other antiviral drug

Yes No

242

Specify other antiviral drug:243

Growth factors

Yes No Unknown

244

G-CSF

yes no

245

GM-CSF

yes no

246

Pegylated G-CSF

yes no

247

TBO-filgrastim

Yes No

248

Other growth factor

yes no

249

Specify other growth factor:250

Corticosteroids

yes no

251

Erythropoietin

yes no

252

RBC transfusion

Yes No

253

Platelet transfusion

Yes No

254

HCT

Yes No

255

Cellular therapy

yes no

256

Other therapy

yes no

257

Specify other therapy:258

First Name: Last Name:

E-mail address: Date: __ __ __ __ - __ __- __ __

Specify the patient's functional status at last contact:

Provide the most recent value for each lab tested since the date of last report:

Report the most recent complete blood count:

Report the most recent lab values:

Other Organ Impairment/Disorder

Specify impairment/disorder:

Renal

Report highest values measured in this reporting period:

Report the lowest values measured in this reporting period:

Cardiac

Vascular

Central nervous system

Endocrine

Gastrointestinal

Genitourinary

Liver Toxicity

Musculoskeletal

Psychiatric

Pulmonary

Skin

Other

Specify which new disease(s) occurred:

Report each infection organism, site and date of diagnosis:

Do not report fever in the absence of infection.  Report the most specific site of infection. 

Specify therapy given for exposure or complications from exposure, since the date of last report:

Specify therapy given:

Center: CRID: 

Form 5001 R1.0: RITN Follow-Up Form

CIBMTR Form 5001 revision 1.0 last updated Monday, December 21, 2015
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 2 / 8



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Visit

100 day 6 months 1 year 2 years > 2 years

Specify:

Vital Status Questions: 1 - 9

Date of actual contact with the patient to determine the medical status for this follow-up report:1 __ __ __ __ - __ __- __ __

Specify the patient's survival status at the date of last contact

Alive Dead

2

Primary cause of death3

Specify:4

What scale was used to determine the patient’s functional status?

Karnofsky Lansky

5

Karnofsky scale (patient age ≥ 16 years)6

Lansky scale (patient age < 16 years)7

Has the patient become pregnant since the date of last report? (Female only)

Yes No Unknown

8

Has the patient fathered any children since the date of last report? (i.e. contributed to any pregnancies) (Male only)

Yes No Unknown

9

Organ Function Questions: 10 - 39

AST (SGOT)

Known Unknown

10

11 U/L µkat/L

Date sample collected:12 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:13 U/L µkat/L

ALT (SGPT)

Known Unknown

14

15 U/L µkat/L

Date sample collected:16 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:17 U/L µkat/L

Total serum bilirubin

Known Unknown

18

19 mg/dL µmol/L

Date sample collected:20 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:21 mg/dL µmol/L

Serum creatinine

Known Unknown

22

23 mg/dL mmol/L µmol/L

Date sample collected:24 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:25 mg/dL mmol/L µmol/L

Serum albumin

Known Unknown

26

27 g/dL g/L

Date sample collected:28 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:29 g/dL g/L

Amylase

Known Unknown

30

31 U/L

International normalized ratio (INR)

Known Unknown

32

(INR)

33

Partial thromboplastin time (PTT)

Known Unknown

34

35 seconds

Reticulocytes

Known Unknown

36

(uncorrected)

37
x 109/L

Was a bone marrow examination performed?

yes no Unknown

38

Date sample collected:39 __ __ __ __ - __ __- __ __

Complete Blood Count Questions: 40 - 56

Was a complete blood count done since the date of last report?

Yes No

40

Date sample collected:41 __ __ __ __ - __ __- __ __

WBC

Known Unknown

42

43 x 109/L (x 103/mm3)

x 106/L

Was G­CSF given ≤ 7 days before date of test?

Yes No

44

Neutrophils

Known Unknown

45

46 %

Lymphocytes

Known Unknown

47

48 %

Hemoglobin

Known Unknown

49

50 g/dL g/L mmol/L

Was RBC transfused < 30 days before date of test?

yes no

51

Hematocrit

Known Unknown

52

53 %

Platelets

Known Unknown

54

55 x 109/L (x 103/mm3)

x 106/L

Were platelets transfused ≤ 7 days before date of test?

Yes No

56

Lymphocyte Analyses Questions: 57 - 70

Were lymphocyte analyses performed?

yes no

57

Date sample collected:58 __ __ __ __ - __ __- __ __

CD3 (T cells)

Known Unknown

59

60 x 109/L (x 103/mm3)

x 106/L

CD4 (T helper cells)

Known Unknown

61

62 x 109/L (x 103/mm3)

x 106/L

CD8 (cytotoxic T cells)

Known Unknown

63

64 x 109/L (x 103/mm3)

x 106/L

CD19

Known Unknown

65

66 x 109/L (x 103/mm3)

x 106/L

CD20 (B lymphocyte cells)

Known Unknown

67

68 x 109/L (x 103/mm3)

x 106/L

CD56 (natural killer (NK) cells)

Known Unknown

69

70 x 109/L (x 103/mm3)

x 106/L

Organ Impairment / Disorders Questions: 71 - 167

Has the patient developed any clinically significant organ impairment or disorder since the date of the last report?

Yes No

71

Chronic kidney disease / renal impairment (persistent decrease in glomerular filtration rate to < 60 ml/min/1.73m2)

Yes No

72

Date of diagnosis:73 __ __ __ __ - __ __- __ __

Serum creatinine

Known Unknown

74

(peak in reporting period)

75 mg/dL mmol/L µmol/L

Date sample collected:76 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

77

(GFR) (calculated) (peak in reporting period)

78 mL/min/1.732

Date sample collected:79 __ __ __ __ - __ __- __ __

Was a renal biopsy performed?

Yes No Unknown

80

Serum creatinine

Known Unknown

81

(lowest in reporting period)

82 mg/dL mmol/L µmol/L

Date sample collected:83 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

84

(GFR) (calculated) (peak in reporting period)

85 mL/min/1.732

Date sample collected:86 __ __ __ __ - __ __- __ __

Hemorrhagic cystitis/hematuria

Yes No

87

Date of diagnosis:88 __ __ __ __ - __ __- __ __

Renal failure requiring dialysis

Yes No

89

Date dialysis started:90 __ __ __ __ - __ __- __ __

Arrhythmia

Yes No

91

(atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmia)

Date of diagnosis:92 __ __ __ __ - __ __- __ __

Congestive heart failure / Cardiomyopathy

Yes No

93

(EF < 40%)

Date of diagnosis:94 __ __ __ __ - __ __- __ __

Specify ejection fraction:95 %

Hypertension requiring therapy

Yes No

96

Date of diagnosis:97 __ __ __ __ - __ __- __ __

Myocardial infarction / Unstable angina

Yes No

98

Date of diagnosis:99 __ __ __ __ - __ __- __ __

Pericarditis

Yes No

100

Date of diagnosis:101 __ __ __ __ - __ __- __ __

Deep vein thrombosis (DVT) / Pulmonary embolism (PE)

Yes No

102

Date of diagnosis:103 __ __ __ __ - __ __- __ __

Was the DVT catheter related?

Yes No

104

Thrombotic microangiopathy

Yes No

105

(TMA)

Date of diagnosis:106 __ __ __ __ - __ __- __ __

CNS hemorrhage

Yes No

107

Date of diagnosis:108 __ __ __ __ - __ __- __ __

Encephalopathy

Yes No

109

(non-infectious)

Date of diagnosis:110 __ __ __ __ - __ __- __ __

Neuropathy

Yes No

111

Date of diagnosis:112 __ __ __ __ - __ __- __ __

Seizures

yes no

113

Date of diagnosis:114 __ __ __ __ - __ __- __ __

Stroke

Yes No

115

Date of diagnosis:116 __ __ __ __ - __ __- __ __

Transient ischemic attack

Yes No

117

(TIA)

Date of diagnosis:118 __ __ __ __ - __ __- __ __

Diabetes / hyperglycemia (requiring chronic treatment)

Yes No

119

Date of diagnosis:120 __ __ __ __ - __ __- __ __

Growth hormone deficiency / growth disturbance

Yes No

121

Date of diagnosis:122 __ __ __ __ - __ __- __ __

Hypothyroidism (requiring replacement therapy)

Yes No

123

Date of diagnosis:124 __ __ __ __ - __ __- __ __

Pancreatitis

Yes No

125

Date of diagnosis:126 __ __ __ __ - __ __- __ __

Diarrhea requiring therapy (requiring chronic treatment)

Yes No

127

Date of diagnosis:128 __ __ __ __ - __ __- __ __

Gastrointestinal (GI) bleeding

Yes No

129

Date of diagnosis:130 __ __ __ __ - __ __- __ __

Gonadal dysfunction / infertility requiring hormone replacement (testosterone or estrogen)

Yes No

131

Date of diagnosis:132 __ __ __ __ - __ __- __ __

Cirrhosis

Yes No

133

Date of diagnosis:134 __ __ __ __ - __ __- __ __

VOD

Yes No

135

Date of diagnosis:136 __ __ __ __ - __ __- __ __

Other non-infectious liver toxicity

Yes No

137

Date of diagnosis:138 __ __ __ __ - __ __- __ __

Avascular necrosis

Yes No

139

Date of diagnosis:140 __ __ __ __ - __ __- __ __

Osteoporosis

Yes No

141

Date of diagnosis:142 __ __ __ __ - __ __- __ __

Depression requiring therapy

Yes No

143

Date of diagnosis:144 __ __ __ __ - __ __- __ __

Anxiety requiring therapy

Yes No

145

Date of diagnosis:146 __ __ __ __ - __ __- __ __

Post-traumatic stress disorder (PTSD) requiring therapy

Yes No

147

Date of diagnosis:148 __ __ __ __ - __ __- __ __

Bronchiolitis obliterans

Yes No

149

Date of diagnosis:150 __ __ __ __ - __ __- __ __

Cryptogenic organizing pneumonia

Yes No

151

(COP/BOOP)

Date of diagnosis:152 __ __ __ __ - __ __- __ __

Fibrosis

Yes No

153

Date of diagnosis:154 __ __ __ __ - __ __- __ __

Interstitial pneumonitis (IPn) / ARDS

Yes No

155

Date of diagnosis:156 __ __ __ __ - __ __- __ __

Pulmonary or diffuse alveolar hemorrhage

Yes No

157

Date of diagnosis:158 __ __ __ __ - __ __- __ __

Strictures (related to exposure)

Yes No

159

Date of diagnosis:160 __ __ __ __ - __ __- __ __

Wounds requiring surgery (related to exposure)

Yes No

161

Date of diagnosis:162 __ __ __ __ - __ __- __ __

Cataracts

Yes No

163

Date of diagnosis:164 __ __ __ __ - __ __- __ __

Other impairment or disorder

Yes No

165

Date of diagnosis:166 __ __ __ __ - __ __- __ __

Specify other impairment / disorder:167

New Malignancy Questions: 168 - 212

Did a new malignancy, myelodysplastic, or myeloproliferative disorder appear since the date of last report?

Yes No

168

Acute myeloid leukemia (AML / ANLL)

yes no

169

Date of diagnosis:170 __ __ __ __ - __ __- __ __

Other leukemia, including ALL

yes no

171

Date of diagnosis:172 __ __ __ __ - __ __- __ __

Specify other leukemia:173

Breast cancer

yes no

174

Date of diagnosis:175 __ __ __ __ - __ __- __ __

Central nervous system (CNS) malignancy

Yes No

176

(e.g. glioblastoma, astrocytoma)

Date of diagnosis:177 __ __ __ __ - __ __- __ __

Clonal cytogenetic abnormality without leukemia or MDS

Yes No

178

Date of diagnosis:179 __ __ __ __ - __ __- __ __

Gastrointestinal malignancy

Yes No

180

(e.g. colon, rectum, stomach, pancreas, intestine)

Date of diagnosis:181 __ __ __ __ - __ __- __ __

Genitourinary malignancy

Yes No

182

(e.g. kidney, bladder, ovary, testicle, genitalia, uterus, cervix)

Date of diagnosis:183 __ __ __ __ - __ __- __ __

Lung cancer

yes no

184

Date of diagnosis:185 __ __ __ __ - __ __- __ __

Hodgkin disease

yes no

186

Date of diagnosis:187 __ __ __ __ - __ __- __ __

Lymphoma or lymphoproliferative disease

Yes No

188

Date of diagnosis:189 __ __ __ __ - __ __- __ __

Was the tumor EBV positive?

yes no

190

Melanoma

Yes No

191

Date of diagnosis:192 __ __ __ __ - __ __- __ __

Basal cell skin malignancy

Yes No

193

Date of diagnosis:194 __ __ __ __ - __ __- __ __

Squamous cell skin malignancy

Yes No

195

Date of diagnosis:196 __ __ __ __ - __ __- __ __

Myelodysplastic syndrome (MDS)

yes no

197

Date of diagnosis:198 __ __ __ __ - __ __- __ __

Myeloproliferative neoplasm (MPN)

yes no

199

Date of diagnosis:200 __ __ __ __ - __ __- __ __

Myelodysplasia / myeloproliferative neoplasm

Yes No

201

Date of diagnosis:202 __ __ __ __ - __ __- __ __

Oropharyngeal cancer (e.g. tongue, buccal mucosa)

Yes No

203

Date of diagnosis:204 __ __ __ __ - __ __- __ __

Sarcoma

Yes No

205

Date of diagnosis:206 __ __ __ __ - __ __- __ __

Thyroid cancer

yes no

207

Date of diagnosis:208 __ __ __ __ - __ __- __ __

Other new malignancy

yes no

209

Date of diagnosis:210 __ __ __ __ - __ __- __ __

Specify other new malignancy:211

Was documentation submitted to the CIBMTR? (e.g. pathology/autopsy report or other documentation)

Yes No

212

Infection Questions: 213 - 219

Did the patient develop a clinically significant infection since the date of last report?

Yes No

213

Infection (1) Questions: 214 - 219

Organism:214

Specify other organism:215

Site:216

Site:217

Site:218

Date of diagnosis:219 __ __ __ __ - __ __- __ __

Therapy Questions: 220 - 258

Was therapy given since the date of last report?

yes no

220

Systemic antibacterial antibiotics

Yes No Unknown

221

Non-absorbable oral antibiotics

Yes No Unknown

222

Systemic antifungal drugs

Yes No Unknown

223

Amphotericin

Yes No

224

(Fungizone) (non-lipid formulation)

Amphotericin

Yes No

225

(e.g. Abelcet, AmBisome, Amphotec) (lipid formulation)

Caspofungin

Yes No

226

Fluconazole

Yes No

227

Isavuconazole

Yes No

228

Itraconazole

Yes No

229

Micafungin

Yes No

230

Posaconazole

Yes No

231

Ravuconazole

Yes No

232

Voriconazole

Yes No

233

Other systemic antifungal drug

Yes No

234

Specify other systemic antifungal drug:235

Antiviral drugs

Yes No Unknown

236

Acyclovir

yes no

237

Foscarnet

Yes No

238

Ganciclovir (DHPG)

yes no

239

Valganciclovir

Yes No

240

(Valcyte)

Valacyclovir

Yes No

241

Other antiviral drug

Yes No

242

Specify other antiviral drug:243

Growth factors

Yes No Unknown

244

G-CSF

yes no

245

GM-CSF

yes no

246

Pegylated G-CSF

yes no

247

TBO-filgrastim

Yes No

248

Other growth factor

yes no

249

Specify other growth factor:250

Corticosteroids

yes no

251

Erythropoietin

yes no

252

RBC transfusion

Yes No

253

Platelet transfusion

Yes No

254

HCT

Yes No

255

Cellular therapy

yes no

256

Other therapy

yes no

257

Specify other therapy:258

First Name: Last Name:

E-mail address: Date: __ __ __ __ - __ __- __ __

Specify the patient's functional status at last contact:

Provide the most recent value for each lab tested since the date of last report:

Report the most recent complete blood count:

Report the most recent lab values:

Other Organ Impairment/Disorder

Specify impairment/disorder:

Renal

Report highest values measured in this reporting period:

Report the lowest values measured in this reporting period:

Cardiac

Vascular

Central nervous system

Endocrine

Gastrointestinal

Genitourinary

Liver Toxicity

Musculoskeletal

Psychiatric

Pulmonary

Skin

Other

Specify which new disease(s) occurred:

Report each infection organism, site and date of diagnosis:

Do not report fever in the absence of infection.  Report the most specific site of infection. 

Specify therapy given for exposure or complications from exposure, since the date of last report:

Specify therapy given:

Center: CRID: 

Form 5001 R1.0: RITN Follow-Up Form

CIBMTR Form 5001 revision 1.0 last updated Monday, December 21, 2015
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 3 / 8



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Visit

100 day 6 months 1 year 2 years > 2 years

Specify:

Vital Status Questions: 1 - 9

Date of actual contact with the patient to determine the medical status for this follow-up report:1 __ __ __ __ - __ __- __ __

Specify the patient's survival status at the date of last contact

Alive Dead

2

Primary cause of death3

Specify:4

What scale was used to determine the patient’s functional status?

Karnofsky Lansky

5

Karnofsky scale (patient age ≥ 16 years)6

Lansky scale (patient age < 16 years)7

Has the patient become pregnant since the date of last report? (Female only)

Yes No Unknown

8

Has the patient fathered any children since the date of last report? (i.e. contributed to any pregnancies) (Male only)

Yes No Unknown

9

Organ Function Questions: 10 - 39

AST (SGOT)

Known Unknown

10

11 U/L µkat/L

Date sample collected:12 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:13 U/L µkat/L

ALT (SGPT)

Known Unknown

14

15 U/L µkat/L

Date sample collected:16 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:17 U/L µkat/L

Total serum bilirubin

Known Unknown

18

19 mg/dL µmol/L

Date sample collected:20 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:21 mg/dL µmol/L

Serum creatinine

Known Unknown

22

23 mg/dL mmol/L µmol/L

Date sample collected:24 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:25 mg/dL mmol/L µmol/L

Serum albumin

Known Unknown

26

27 g/dL g/L

Date sample collected:28 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:29 g/dL g/L

Amylase

Known Unknown

30

31 U/L

International normalized ratio (INR)

Known Unknown

32

(INR)

33

Partial thromboplastin time (PTT)

Known Unknown

34

35 seconds

Reticulocytes

Known Unknown

36

(uncorrected)

37
x 109/L

Was a bone marrow examination performed?

yes no Unknown

38

Date sample collected:39 __ __ __ __ - __ __- __ __

Complete Blood Count Questions: 40 - 56

Was a complete blood count done since the date of last report?

Yes No

40

Date sample collected:41 __ __ __ __ - __ __- __ __

WBC

Known Unknown

42

43 x 109/L (x 103/mm3)

x 106/L

Was G­CSF given ≤ 7 days before date of test?

Yes No

44

Neutrophils

Known Unknown

45

46 %

Lymphocytes

Known Unknown

47

48 %

Hemoglobin

Known Unknown

49

50 g/dL g/L mmol/L

Was RBC transfused < 30 days before date of test?

yes no

51

Hematocrit

Known Unknown

52

53 %

Platelets

Known Unknown

54

55 x 109/L (x 103/mm3)

x 106/L

Were platelets transfused ≤ 7 days before date of test?

Yes No

56

Lymphocyte Analyses Questions: 57 - 70

Were lymphocyte analyses performed?

yes no

57

Date sample collected:58 __ __ __ __ - __ __- __ __

CD3 (T cells)

Known Unknown

59

60 x 109/L (x 103/mm3)

x 106/L

CD4 (T helper cells)

Known Unknown

61

62 x 109/L (x 103/mm3)

x 106/L

CD8 (cytotoxic T cells)

Known Unknown

63

64 x 109/L (x 103/mm3)

x 106/L

CD19

Known Unknown

65

66 x 109/L (x 103/mm3)

x 106/L

CD20 (B lymphocyte cells)

Known Unknown

67

68 x 109/L (x 103/mm3)

x 106/L

CD56 (natural killer (NK) cells)

Known Unknown

69

70 x 109/L (x 103/mm3)

x 106/L

Organ Impairment / Disorders Questions: 71 - 167

Has the patient developed any clinically significant organ impairment or disorder since the date of the last report?

Yes No

71

Chronic kidney disease / renal impairment (persistent decrease in glomerular filtration rate to < 60 ml/min/1.73m2)

Yes No

72

Date of diagnosis:73 __ __ __ __ - __ __- __ __

Serum creatinine

Known Unknown

74

(peak in reporting period)

75 mg/dL mmol/L µmol/L

Date sample collected:76 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

77

(GFR) (calculated) (peak in reporting period)

78 mL/min/1.732

Date sample collected:79 __ __ __ __ - __ __- __ __

Was a renal biopsy performed?

Yes No Unknown

80

Serum creatinine

Known Unknown

81

(lowest in reporting period)

82 mg/dL mmol/L µmol/L

Date sample collected:83 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

84

(GFR) (calculated) (peak in reporting period)

85 mL/min/1.732

Date sample collected:86 __ __ __ __ - __ __- __ __

Hemorrhagic cystitis/hematuria

Yes No

87

Date of diagnosis:88 __ __ __ __ - __ __- __ __

Renal failure requiring dialysis

Yes No

89

Date dialysis started:90 __ __ __ __ - __ __- __ __

Arrhythmia

Yes No

91

(atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmia)

Date of diagnosis:92 __ __ __ __ - __ __- __ __

Congestive heart failure / Cardiomyopathy

Yes No

93

(EF < 40%)

Date of diagnosis:94 __ __ __ __ - __ __- __ __

Specify ejection fraction:95 %

Hypertension requiring therapy

Yes No

96

Date of diagnosis:97 __ __ __ __ - __ __- __ __

Myocardial infarction / Unstable angina

Yes No

98

Date of diagnosis:99 __ __ __ __ - __ __- __ __

Pericarditis

Yes No

100

Date of diagnosis:101 __ __ __ __ - __ __- __ __

Deep vein thrombosis (DVT) / Pulmonary embolism (PE)

Yes No

102

Date of diagnosis:103 __ __ __ __ - __ __- __ __

Was the DVT catheter related?

Yes No

104

Thrombotic microangiopathy

Yes No

105

(TMA)

Date of diagnosis:106 __ __ __ __ - __ __- __ __

CNS hemorrhage

Yes No

107

Date of diagnosis:108 __ __ __ __ - __ __- __ __

Encephalopathy

Yes No

109

(non-infectious)

Date of diagnosis:110 __ __ __ __ - __ __- __ __

Neuropathy

Yes No

111

Date of diagnosis:112 __ __ __ __ - __ __- __ __

Seizures

yes no

113

Date of diagnosis:114 __ __ __ __ - __ __- __ __

Stroke

Yes No

115

Date of diagnosis:116 __ __ __ __ - __ __- __ __

Transient ischemic attack

Yes No

117

(TIA)

Date of diagnosis:118 __ __ __ __ - __ __- __ __

Diabetes / hyperglycemia (requiring chronic treatment)

Yes No

119

Date of diagnosis:120 __ __ __ __ - __ __- __ __

Growth hormone deficiency / growth disturbance

Yes No

121

Date of diagnosis:122 __ __ __ __ - __ __- __ __

Hypothyroidism (requiring replacement therapy)

Yes No

123

Date of diagnosis:124 __ __ __ __ - __ __- __ __

Pancreatitis

Yes No

125

Date of diagnosis:126 __ __ __ __ - __ __- __ __

Diarrhea requiring therapy (requiring chronic treatment)

Yes No

127

Date of diagnosis:128 __ __ __ __ - __ __- __ __

Gastrointestinal (GI) bleeding

Yes No

129

Date of diagnosis:130 __ __ __ __ - __ __- __ __

Gonadal dysfunction / infertility requiring hormone replacement (testosterone or estrogen)

Yes No

131

Date of diagnosis:132 __ __ __ __ - __ __- __ __

Cirrhosis

Yes No

133

Date of diagnosis:134 __ __ __ __ - __ __- __ __

VOD

Yes No

135

Date of diagnosis:136 __ __ __ __ - __ __- __ __

Other non-infectious liver toxicity

Yes No

137

Date of diagnosis:138 __ __ __ __ - __ __- __ __

Avascular necrosis

Yes No

139

Date of diagnosis:140 __ __ __ __ - __ __- __ __

Osteoporosis

Yes No

141

Date of diagnosis:142 __ __ __ __ - __ __- __ __

Depression requiring therapy

Yes No

143

Date of diagnosis:144 __ __ __ __ - __ __- __ __

Anxiety requiring therapy

Yes No

145

Date of diagnosis:146 __ __ __ __ - __ __- __ __

Post-traumatic stress disorder (PTSD) requiring therapy

Yes No

147

Date of diagnosis:148 __ __ __ __ - __ __- __ __

Bronchiolitis obliterans

Yes No

149

Date of diagnosis:150 __ __ __ __ - __ __- __ __

Cryptogenic organizing pneumonia

Yes No

151

(COP/BOOP)

Date of diagnosis:152 __ __ __ __ - __ __- __ __

Fibrosis

Yes No

153

Date of diagnosis:154 __ __ __ __ - __ __- __ __

Interstitial pneumonitis (IPn) / ARDS

Yes No

155

Date of diagnosis:156 __ __ __ __ - __ __- __ __

Pulmonary or diffuse alveolar hemorrhage

Yes No

157

Date of diagnosis:158 __ __ __ __ - __ __- __ __

Strictures (related to exposure)

Yes No

159

Date of diagnosis:160 __ __ __ __ - __ __- __ __

Wounds requiring surgery (related to exposure)

Yes No

161

Date of diagnosis:162 __ __ __ __ - __ __- __ __

Cataracts

Yes No

163

Date of diagnosis:164 __ __ __ __ - __ __- __ __

Other impairment or disorder

Yes No

165

Date of diagnosis:166 __ __ __ __ - __ __- __ __

Specify other impairment / disorder:167

New Malignancy Questions: 168 - 212

Did a new malignancy, myelodysplastic, or myeloproliferative disorder appear since the date of last report?

Yes No

168

Acute myeloid leukemia (AML / ANLL)

yes no

169

Date of diagnosis:170 __ __ __ __ - __ __- __ __

Other leukemia, including ALL

yes no

171

Date of diagnosis:172 __ __ __ __ - __ __- __ __

Specify other leukemia:173

Breast cancer

yes no

174

Date of diagnosis:175 __ __ __ __ - __ __- __ __

Central nervous system (CNS) malignancy

Yes No

176

(e.g. glioblastoma, astrocytoma)

Date of diagnosis:177 __ __ __ __ - __ __- __ __

Clonal cytogenetic abnormality without leukemia or MDS

Yes No

178

Date of diagnosis:179 __ __ __ __ - __ __- __ __

Gastrointestinal malignancy

Yes No

180

(e.g. colon, rectum, stomach, pancreas, intestine)

Date of diagnosis:181 __ __ __ __ - __ __- __ __

Genitourinary malignancy

Yes No

182

(e.g. kidney, bladder, ovary, testicle, genitalia, uterus, cervix)

Date of diagnosis:183 __ __ __ __ - __ __- __ __

Lung cancer

yes no

184

Date of diagnosis:185 __ __ __ __ - __ __- __ __

Hodgkin disease

yes no

186

Date of diagnosis:187 __ __ __ __ - __ __- __ __

Lymphoma or lymphoproliferative disease

Yes No

188

Date of diagnosis:189 __ __ __ __ - __ __- __ __

Was the tumor EBV positive?

yes no

190

Melanoma

Yes No

191

Date of diagnosis:192 __ __ __ __ - __ __- __ __

Basal cell skin malignancy

Yes No

193

Date of diagnosis:194 __ __ __ __ - __ __- __ __

Squamous cell skin malignancy

Yes No

195

Date of diagnosis:196 __ __ __ __ - __ __- __ __

Myelodysplastic syndrome (MDS)

yes no

197

Date of diagnosis:198 __ __ __ __ - __ __- __ __

Myeloproliferative neoplasm (MPN)

yes no

199

Date of diagnosis:200 __ __ __ __ - __ __- __ __

Myelodysplasia / myeloproliferative neoplasm

Yes No

201

Date of diagnosis:202 __ __ __ __ - __ __- __ __

Oropharyngeal cancer (e.g. tongue, buccal mucosa)

Yes No

203

Date of diagnosis:204 __ __ __ __ - __ __- __ __

Sarcoma

Yes No

205

Date of diagnosis:206 __ __ __ __ - __ __- __ __

Thyroid cancer

yes no

207

Date of diagnosis:208 __ __ __ __ - __ __- __ __

Other new malignancy

yes no

209

Date of diagnosis:210 __ __ __ __ - __ __- __ __

Specify other new malignancy:211

Was documentation submitted to the CIBMTR? (e.g. pathology/autopsy report or other documentation)

Yes No

212

Infection Questions: 213 - 219

Did the patient develop a clinically significant infection since the date of last report?

Yes No

213

Infection (1) Questions: 214 - 219

Organism:214

Specify other organism:215

Site:216

Site:217

Site:218

Date of diagnosis:219 __ __ __ __ - __ __- __ __

Therapy Questions: 220 - 258

Was therapy given since the date of last report?

yes no

220

Systemic antibacterial antibiotics

Yes No Unknown

221

Non-absorbable oral antibiotics

Yes No Unknown

222

Systemic antifungal drugs

Yes No Unknown

223

Amphotericin

Yes No

224

(Fungizone) (non-lipid formulation)

Amphotericin

Yes No

225

(e.g. Abelcet, AmBisome, Amphotec) (lipid formulation)

Caspofungin

Yes No

226

Fluconazole

Yes No

227

Isavuconazole

Yes No

228

Itraconazole

Yes No

229

Micafungin

Yes No

230

Posaconazole

Yes No

231

Ravuconazole

Yes No

232

Voriconazole

Yes No

233

Other systemic antifungal drug

Yes No

234

Specify other systemic antifungal drug:235

Antiviral drugs

Yes No Unknown

236

Acyclovir

yes no

237

Foscarnet

Yes No

238

Ganciclovir (DHPG)

yes no

239

Valganciclovir

Yes No

240

(Valcyte)

Valacyclovir

Yes No

241

Other antiviral drug

Yes No

242

Specify other antiviral drug:243

Growth factors

Yes No Unknown

244

G-CSF

yes no

245

GM-CSF

yes no

246

Pegylated G-CSF

yes no

247

TBO-filgrastim

Yes No

248

Other growth factor

yes no

249

Specify other growth factor:250

Corticosteroids

yes no

251

Erythropoietin

yes no

252

RBC transfusion

Yes No

253

Platelet transfusion

Yes No

254

HCT

Yes No

255

Cellular therapy

yes no

256

Other therapy

yes no

257

Specify other therapy:258

First Name: Last Name:

E-mail address: Date: __ __ __ __ - __ __- __ __

Specify the patient's functional status at last contact:

Provide the most recent value for each lab tested since the date of last report:

Report the most recent complete blood count:

Report the most recent lab values:

Other Organ Impairment/Disorder

Specify impairment/disorder:

Renal

Report highest values measured in this reporting period:

Report the lowest values measured in this reporting period:

Cardiac

Vascular

Central nervous system

Endocrine

Gastrointestinal

Genitourinary

Liver Toxicity

Musculoskeletal

Psychiatric

Pulmonary

Skin

Other

Specify which new disease(s) occurred:

Report each infection organism, site and date of diagnosis:

Do not report fever in the absence of infection.  Report the most specific site of infection. 

Specify therapy given for exposure or complications from exposure, since the date of last report:

Specify therapy given:

Center: CRID: 

Form 5001 R1.0: RITN Follow-Up Form

CIBMTR Form 5001 revision 1.0 last updated Monday, December 21, 2015
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 4 / 8



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Visit

100 day 6 months 1 year 2 years > 2 years

Specify:

Vital Status Questions: 1 - 9

Date of actual contact with the patient to determine the medical status for this follow-up report:1 __ __ __ __ - __ __- __ __

Specify the patient's survival status at the date of last contact

Alive Dead

2

Primary cause of death3

Specify:4

What scale was used to determine the patient’s functional status?

Karnofsky Lansky

5

Karnofsky scale (patient age ≥ 16 years)6

Lansky scale (patient age < 16 years)7

Has the patient become pregnant since the date of last report? (Female only)

Yes No Unknown

8

Has the patient fathered any children since the date of last report? (i.e. contributed to any pregnancies) (Male only)

Yes No Unknown

9

Organ Function Questions: 10 - 39

AST (SGOT)

Known Unknown

10

11 U/L µkat/L

Date sample collected:12 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:13 U/L µkat/L

ALT (SGPT)

Known Unknown

14

15 U/L µkat/L

Date sample collected:16 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:17 U/L µkat/L

Total serum bilirubin

Known Unknown

18

19 mg/dL µmol/L

Date sample collected:20 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:21 mg/dL µmol/L

Serum creatinine

Known Unknown

22

23 mg/dL mmol/L µmol/L

Date sample collected:24 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:25 mg/dL mmol/L µmol/L

Serum albumin

Known Unknown

26

27 g/dL g/L

Date sample collected:28 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:29 g/dL g/L

Amylase

Known Unknown

30

31 U/L

International normalized ratio (INR)

Known Unknown

32

(INR)

33

Partial thromboplastin time (PTT)

Known Unknown

34

35 seconds

Reticulocytes

Known Unknown

36

(uncorrected)

37
x 109/L

Was a bone marrow examination performed?

yes no Unknown

38

Date sample collected:39 __ __ __ __ - __ __- __ __

Complete Blood Count Questions: 40 - 56

Was a complete blood count done since the date of last report?

Yes No

40

Date sample collected:41 __ __ __ __ - __ __- __ __

WBC

Known Unknown

42

43 x 109/L (x 103/mm3)

x 106/L

Was G­CSF given ≤ 7 days before date of test?

Yes No

44

Neutrophils

Known Unknown

45

46 %

Lymphocytes

Known Unknown

47

48 %

Hemoglobin

Known Unknown

49

50 g/dL g/L mmol/L

Was RBC transfused < 30 days before date of test?

yes no

51

Hematocrit

Known Unknown

52

53 %

Platelets

Known Unknown

54

55 x 109/L (x 103/mm3)

x 106/L

Were platelets transfused ≤ 7 days before date of test?

Yes No

56

Lymphocyte Analyses Questions: 57 - 70

Were lymphocyte analyses performed?

yes no

57

Date sample collected:58 __ __ __ __ - __ __- __ __

CD3 (T cells)

Known Unknown

59

60 x 109/L (x 103/mm3)

x 106/L

CD4 (T helper cells)

Known Unknown

61

62 x 109/L (x 103/mm3)

x 106/L

CD8 (cytotoxic T cells)

Known Unknown

63

64 x 109/L (x 103/mm3)

x 106/L

CD19

Known Unknown

65

66 x 109/L (x 103/mm3)

x 106/L

CD20 (B lymphocyte cells)

Known Unknown

67

68 x 109/L (x 103/mm3)

x 106/L

CD56 (natural killer (NK) cells)

Known Unknown

69

70 x 109/L (x 103/mm3)

x 106/L

Organ Impairment / Disorders Questions: 71 - 167

Has the patient developed any clinically significant organ impairment or disorder since the date of the last report?

Yes No

71

Chronic kidney disease / renal impairment (persistent decrease in glomerular filtration rate to < 60 ml/min/1.73m2)

Yes No

72

Date of diagnosis:73 __ __ __ __ - __ __- __ __

Serum creatinine

Known Unknown

74

(peak in reporting period)

75 mg/dL mmol/L µmol/L

Date sample collected:76 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

77

(GFR) (calculated) (peak in reporting period)

78 mL/min/1.732

Date sample collected:79 __ __ __ __ - __ __- __ __

Was a renal biopsy performed?

Yes No Unknown

80

Serum creatinine

Known Unknown

81

(lowest in reporting period)

82 mg/dL mmol/L µmol/L

Date sample collected:83 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

84

(GFR) (calculated) (peak in reporting period)

85 mL/min/1.732

Date sample collected:86 __ __ __ __ - __ __- __ __

Hemorrhagic cystitis/hematuria

Yes No

87

Date of diagnosis:88 __ __ __ __ - __ __- __ __

Renal failure requiring dialysis

Yes No

89

Date dialysis started:90 __ __ __ __ - __ __- __ __

Arrhythmia

Yes No

91

(atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmia)

Date of diagnosis:92 __ __ __ __ - __ __- __ __

Congestive heart failure / Cardiomyopathy

Yes No

93

(EF < 40%)

Date of diagnosis:94 __ __ __ __ - __ __- __ __

Specify ejection fraction:95 %

Hypertension requiring therapy

Yes No

96

Date of diagnosis:97 __ __ __ __ - __ __- __ __

Myocardial infarction / Unstable angina

Yes No

98

Date of diagnosis:99 __ __ __ __ - __ __- __ __

Pericarditis

Yes No

100

Date of diagnosis:101 __ __ __ __ - __ __- __ __

Deep vein thrombosis (DVT) / Pulmonary embolism (PE)

Yes No

102

Date of diagnosis:103 __ __ __ __ - __ __- __ __

Was the DVT catheter related?

Yes No

104

Thrombotic microangiopathy

Yes No

105

(TMA)

Date of diagnosis:106 __ __ __ __ - __ __- __ __

CNS hemorrhage

Yes No

107

Date of diagnosis:108 __ __ __ __ - __ __- __ __

Encephalopathy

Yes No

109

(non-infectious)

Date of diagnosis:110 __ __ __ __ - __ __- __ __

Neuropathy

Yes No

111

Date of diagnosis:112 __ __ __ __ - __ __- __ __

Seizures

yes no

113

Date of diagnosis:114 __ __ __ __ - __ __- __ __

Stroke

Yes No

115

Date of diagnosis:116 __ __ __ __ - __ __- __ __

Transient ischemic attack

Yes No

117

(TIA)

Date of diagnosis:118 __ __ __ __ - __ __- __ __

Diabetes / hyperglycemia (requiring chronic treatment)

Yes No

119

Date of diagnosis:120 __ __ __ __ - __ __- __ __

Growth hormone deficiency / growth disturbance

Yes No

121

Date of diagnosis:122 __ __ __ __ - __ __- __ __

Hypothyroidism (requiring replacement therapy)

Yes No

123

Date of diagnosis:124 __ __ __ __ - __ __- __ __

Pancreatitis

Yes No

125

Date of diagnosis:126 __ __ __ __ - __ __- __ __

Diarrhea requiring therapy (requiring chronic treatment)

Yes No

127

Date of diagnosis:128 __ __ __ __ - __ __- __ __

Gastrointestinal (GI) bleeding

Yes No

129

Date of diagnosis:130 __ __ __ __ - __ __- __ __

Gonadal dysfunction / infertility requiring hormone replacement (testosterone or estrogen)

Yes No

131

Date of diagnosis:132 __ __ __ __ - __ __- __ __

Cirrhosis

Yes No

133

Date of diagnosis:134 __ __ __ __ - __ __- __ __

VOD

Yes No

135

Date of diagnosis:136 __ __ __ __ - __ __- __ __

Other non-infectious liver toxicity

Yes No

137

Date of diagnosis:138 __ __ __ __ - __ __- __ __

Avascular necrosis

Yes No

139

Date of diagnosis:140 __ __ __ __ - __ __- __ __

Osteoporosis

Yes No

141

Date of diagnosis:142 __ __ __ __ - __ __- __ __

Depression requiring therapy

Yes No

143

Date of diagnosis:144 __ __ __ __ - __ __- __ __

Anxiety requiring therapy

Yes No

145

Date of diagnosis:146 __ __ __ __ - __ __- __ __

Post-traumatic stress disorder (PTSD) requiring therapy

Yes No

147

Date of diagnosis:148 __ __ __ __ - __ __- __ __

Bronchiolitis obliterans

Yes No

149

Date of diagnosis:150 __ __ __ __ - __ __- __ __

Cryptogenic organizing pneumonia

Yes No

151

(COP/BOOP)

Date of diagnosis:152 __ __ __ __ - __ __- __ __

Fibrosis

Yes No

153

Date of diagnosis:154 __ __ __ __ - __ __- __ __

Interstitial pneumonitis (IPn) / ARDS

Yes No

155

Date of diagnosis:156 __ __ __ __ - __ __- __ __

Pulmonary or diffuse alveolar hemorrhage

Yes No

157

Date of diagnosis:158 __ __ __ __ - __ __- __ __

Strictures (related to exposure)

Yes No

159

Date of diagnosis:160 __ __ __ __ - __ __- __ __

Wounds requiring surgery (related to exposure)

Yes No

161

Date of diagnosis:162 __ __ __ __ - __ __- __ __

Cataracts

Yes No

163

Date of diagnosis:164 __ __ __ __ - __ __- __ __

Other impairment or disorder

Yes No

165

Date of diagnosis:166 __ __ __ __ - __ __- __ __

Specify other impairment / disorder:167

New Malignancy Questions: 168 - 212

Did a new malignancy, myelodysplastic, or myeloproliferative disorder appear since the date of last report?

Yes No

168

Acute myeloid leukemia (AML / ANLL)

yes no

169

Date of diagnosis:170 __ __ __ __ - __ __- __ __

Other leukemia, including ALL

yes no

171

Date of diagnosis:172 __ __ __ __ - __ __- __ __

Specify other leukemia:173

Breast cancer

yes no

174

Date of diagnosis:175 __ __ __ __ - __ __- __ __

Central nervous system (CNS) malignancy

Yes No

176

(e.g. glioblastoma, astrocytoma)

Date of diagnosis:177 __ __ __ __ - __ __- __ __

Clonal cytogenetic abnormality without leukemia or MDS

Yes No

178

Date of diagnosis:179 __ __ __ __ - __ __- __ __

Gastrointestinal malignancy

Yes No

180

(e.g. colon, rectum, stomach, pancreas, intestine)

Date of diagnosis:181 __ __ __ __ - __ __- __ __

Genitourinary malignancy

Yes No

182

(e.g. kidney, bladder, ovary, testicle, genitalia, uterus, cervix)

Date of diagnosis:183 __ __ __ __ - __ __- __ __

Lung cancer

yes no

184

Date of diagnosis:185 __ __ __ __ - __ __- __ __

Hodgkin disease

yes no

186

Date of diagnosis:187 __ __ __ __ - __ __- __ __

Lymphoma or lymphoproliferative disease

Yes No

188

Date of diagnosis:189 __ __ __ __ - __ __- __ __

Was the tumor EBV positive?

yes no

190

Melanoma

Yes No

191

Date of diagnosis:192 __ __ __ __ - __ __- __ __

Basal cell skin malignancy

Yes No

193

Date of diagnosis:194 __ __ __ __ - __ __- __ __

Squamous cell skin malignancy

Yes No

195

Date of diagnosis:196 __ __ __ __ - __ __- __ __

Myelodysplastic syndrome (MDS)

yes no

197

Date of diagnosis:198 __ __ __ __ - __ __- __ __

Myeloproliferative neoplasm (MPN)

yes no

199

Date of diagnosis:200 __ __ __ __ - __ __- __ __

Myelodysplasia / myeloproliferative neoplasm

Yes No

201

Date of diagnosis:202 __ __ __ __ - __ __- __ __

Oropharyngeal cancer (e.g. tongue, buccal mucosa)

Yes No

203

Date of diagnosis:204 __ __ __ __ - __ __- __ __

Sarcoma

Yes No

205

Date of diagnosis:206 __ __ __ __ - __ __- __ __

Thyroid cancer

yes no

207

Date of diagnosis:208 __ __ __ __ - __ __- __ __

Other new malignancy

yes no

209

Date of diagnosis:210 __ __ __ __ - __ __- __ __

Specify other new malignancy:211

Was documentation submitted to the CIBMTR? (e.g. pathology/autopsy report or other documentation)

Yes No

212

Infection Questions: 213 - 219

Did the patient develop a clinically significant infection since the date of last report?

Yes No

213

Infection (1) Questions: 214 - 219

Organism:214

Specify other organism:215

Site:216

Site:217

Site:218

Date of diagnosis:219 __ __ __ __ - __ __- __ __

Therapy Questions: 220 - 258

Was therapy given since the date of last report?

yes no

220

Systemic antibacterial antibiotics

Yes No Unknown

221

Non-absorbable oral antibiotics

Yes No Unknown

222

Systemic antifungal drugs

Yes No Unknown

223

Amphotericin

Yes No

224

(Fungizone) (non-lipid formulation)

Amphotericin

Yes No

225

(e.g. Abelcet, AmBisome, Amphotec) (lipid formulation)

Caspofungin

Yes No

226

Fluconazole

Yes No

227

Isavuconazole

Yes No

228

Itraconazole

Yes No

229

Micafungin

Yes No

230

Posaconazole

Yes No

231

Ravuconazole

Yes No

232

Voriconazole

Yes No

233

Other systemic antifungal drug

Yes No

234

Specify other systemic antifungal drug:235

Antiviral drugs

Yes No Unknown

236

Acyclovir

yes no

237

Foscarnet

Yes No

238

Ganciclovir (DHPG)

yes no

239

Valganciclovir

Yes No

240

(Valcyte)

Valacyclovir

Yes No

241

Other antiviral drug

Yes No

242

Specify other antiviral drug:243

Growth factors

Yes No Unknown

244

G-CSF

yes no

245

GM-CSF

yes no

246

Pegylated G-CSF

yes no

247

TBO-filgrastim

Yes No

248

Other growth factor

yes no

249

Specify other growth factor:250

Corticosteroids

yes no

251

Erythropoietin

yes no

252

RBC transfusion

Yes No

253

Platelet transfusion

Yes No

254

HCT

Yes No

255

Cellular therapy

yes no

256

Other therapy

yes no

257

Specify other therapy:258

First Name: Last Name:

E-mail address: Date: __ __ __ __ - __ __- __ __

Specify the patient's functional status at last contact:

Provide the most recent value for each lab tested since the date of last report:

Report the most recent complete blood count:

Report the most recent lab values:

Other Organ Impairment/Disorder

Specify impairment/disorder:

Renal

Report highest values measured in this reporting period:

Report the lowest values measured in this reporting period:

Cardiac

Vascular

Central nervous system

Endocrine

Gastrointestinal

Genitourinary

Liver Toxicity

Musculoskeletal

Psychiatric

Pulmonary

Skin

Other

Specify which new disease(s) occurred:

Report each infection organism, site and date of diagnosis:

Do not report fever in the absence of infection.  Report the most specific site of infection. 

Specify therapy given for exposure or complications from exposure, since the date of last report:

Specify therapy given:

Center: CRID: 

Form 5001 R1.0: RITN Follow-Up Form

CIBMTR Form 5001 revision 1.0 last updated Monday, December 21, 2015
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 5 / 8



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Visit

100 day 6 months 1 year 2 years > 2 years

Specify:

Vital Status Questions: 1 - 9

Date of actual contact with the patient to determine the medical status for this follow-up report:1 __ __ __ __ - __ __- __ __

Specify the patient's survival status at the date of last contact

Alive Dead

2

Primary cause of death3

Specify:4

What scale was used to determine the patient’s functional status?

Karnofsky Lansky

5

Karnofsky scale (patient age ≥ 16 years)6

Lansky scale (patient age < 16 years)7

Has the patient become pregnant since the date of last report? (Female only)

Yes No Unknown

8

Has the patient fathered any children since the date of last report? (i.e. contributed to any pregnancies) (Male only)

Yes No Unknown

9

Organ Function Questions: 10 - 39

AST (SGOT)

Known Unknown

10

11 U/L µkat/L

Date sample collected:12 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:13 U/L µkat/L

ALT (SGPT)

Known Unknown

14

15 U/L µkat/L

Date sample collected:16 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:17 U/L µkat/L

Total serum bilirubin

Known Unknown

18

19 mg/dL µmol/L

Date sample collected:20 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:21 mg/dL µmol/L

Serum creatinine

Known Unknown

22

23 mg/dL mmol/L µmol/L

Date sample collected:24 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:25 mg/dL mmol/L µmol/L

Serum albumin

Known Unknown

26

27 g/dL g/L

Date sample collected:28 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:29 g/dL g/L

Amylase

Known Unknown

30

31 U/L

International normalized ratio (INR)

Known Unknown

32

(INR)

33

Partial thromboplastin time (PTT)

Known Unknown

34

35 seconds

Reticulocytes

Known Unknown

36

(uncorrected)

37
x 109/L

Was a bone marrow examination performed?

yes no Unknown

38

Date sample collected:39 __ __ __ __ - __ __- __ __

Complete Blood Count Questions: 40 - 56

Was a complete blood count done since the date of last report?

Yes No

40

Date sample collected:41 __ __ __ __ - __ __- __ __

WBC

Known Unknown

42

43 x 109/L (x 103/mm3)

x 106/L

Was G­CSF given ≤ 7 days before date of test?

Yes No

44

Neutrophils

Known Unknown

45

46 %

Lymphocytes

Known Unknown

47

48 %

Hemoglobin

Known Unknown

49

50 g/dL g/L mmol/L

Was RBC transfused < 30 days before date of test?

yes no

51

Hematocrit

Known Unknown

52

53 %

Platelets

Known Unknown

54

55 x 109/L (x 103/mm3)

x 106/L

Were platelets transfused ≤ 7 days before date of test?

Yes No

56

Lymphocyte Analyses Questions: 57 - 70

Were lymphocyte analyses performed?

yes no

57

Date sample collected:58 __ __ __ __ - __ __- __ __

CD3 (T cells)

Known Unknown

59

60 x 109/L (x 103/mm3)

x 106/L

CD4 (T helper cells)

Known Unknown

61

62 x 109/L (x 103/mm3)

x 106/L

CD8 (cytotoxic T cells)

Known Unknown

63

64 x 109/L (x 103/mm3)

x 106/L

CD19

Known Unknown

65

66 x 109/L (x 103/mm3)

x 106/L

CD20 (B lymphocyte cells)

Known Unknown

67

68 x 109/L (x 103/mm3)

x 106/L

CD56 (natural killer (NK) cells)

Known Unknown

69

70 x 109/L (x 103/mm3)

x 106/L

Organ Impairment / Disorders Questions: 71 - 167

Has the patient developed any clinically significant organ impairment or disorder since the date of the last report?

Yes No

71

Chronic kidney disease / renal impairment (persistent decrease in glomerular filtration rate to < 60 ml/min/1.73m2)

Yes No

72

Date of diagnosis:73 __ __ __ __ - __ __- __ __

Serum creatinine

Known Unknown

74

(peak in reporting period)

75 mg/dL mmol/L µmol/L

Date sample collected:76 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

77

(GFR) (calculated) (peak in reporting period)

78 mL/min/1.732

Date sample collected:79 __ __ __ __ - __ __- __ __

Was a renal biopsy performed?

Yes No Unknown

80

Serum creatinine

Known Unknown

81

(lowest in reporting period)

82 mg/dL mmol/L µmol/L

Date sample collected:83 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

84

(GFR) (calculated) (peak in reporting period)

85 mL/min/1.732

Date sample collected:86 __ __ __ __ - __ __- __ __

Hemorrhagic cystitis/hematuria

Yes No

87

Date of diagnosis:88 __ __ __ __ - __ __- __ __

Renal failure requiring dialysis

Yes No

89

Date dialysis started:90 __ __ __ __ - __ __- __ __

Arrhythmia

Yes No

91

(atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmia)

Date of diagnosis:92 __ __ __ __ - __ __- __ __

Congestive heart failure / Cardiomyopathy

Yes No

93

(EF < 40%)

Date of diagnosis:94 __ __ __ __ - __ __- __ __

Specify ejection fraction:95 %

Hypertension requiring therapy

Yes No

96

Date of diagnosis:97 __ __ __ __ - __ __- __ __

Myocardial infarction / Unstable angina

Yes No

98

Date of diagnosis:99 __ __ __ __ - __ __- __ __

Pericarditis

Yes No

100

Date of diagnosis:101 __ __ __ __ - __ __- __ __

Deep vein thrombosis (DVT) / Pulmonary embolism (PE)

Yes No

102

Date of diagnosis:103 __ __ __ __ - __ __- __ __

Was the DVT catheter related?

Yes No

104

Thrombotic microangiopathy

Yes No

105

(TMA)

Date of diagnosis:106 __ __ __ __ - __ __- __ __

CNS hemorrhage

Yes No

107

Date of diagnosis:108 __ __ __ __ - __ __- __ __

Encephalopathy

Yes No

109

(non-infectious)

Date of diagnosis:110 __ __ __ __ - __ __- __ __

Neuropathy

Yes No

111

Date of diagnosis:112 __ __ __ __ - __ __- __ __

Seizures

yes no

113

Date of diagnosis:114 __ __ __ __ - __ __- __ __

Stroke

Yes No

115

Date of diagnosis:116 __ __ __ __ - __ __- __ __

Transient ischemic attack

Yes No

117

(TIA)

Date of diagnosis:118 __ __ __ __ - __ __- __ __

Diabetes / hyperglycemia (requiring chronic treatment)

Yes No

119

Date of diagnosis:120 __ __ __ __ - __ __- __ __

Growth hormone deficiency / growth disturbance

Yes No

121

Date of diagnosis:122 __ __ __ __ - __ __- __ __

Hypothyroidism (requiring replacement therapy)

Yes No

123

Date of diagnosis:124 __ __ __ __ - __ __- __ __

Pancreatitis

Yes No

125

Date of diagnosis:126 __ __ __ __ - __ __- __ __

Diarrhea requiring therapy (requiring chronic treatment)

Yes No

127

Date of diagnosis:128 __ __ __ __ - __ __- __ __

Gastrointestinal (GI) bleeding

Yes No

129

Date of diagnosis:130 __ __ __ __ - __ __- __ __

Gonadal dysfunction / infertility requiring hormone replacement (testosterone or estrogen)

Yes No

131

Date of diagnosis:132 __ __ __ __ - __ __- __ __

Cirrhosis

Yes No

133

Date of diagnosis:134 __ __ __ __ - __ __- __ __

VOD

Yes No

135

Date of diagnosis:136 __ __ __ __ - __ __- __ __

Other non-infectious liver toxicity

Yes No

137

Date of diagnosis:138 __ __ __ __ - __ __- __ __

Avascular necrosis

Yes No

139

Date of diagnosis:140 __ __ __ __ - __ __- __ __

Osteoporosis

Yes No

141

Date of diagnosis:142 __ __ __ __ - __ __- __ __

Depression requiring therapy

Yes No

143

Date of diagnosis:144 __ __ __ __ - __ __- __ __

Anxiety requiring therapy

Yes No

145

Date of diagnosis:146 __ __ __ __ - __ __- __ __

Post-traumatic stress disorder (PTSD) requiring therapy

Yes No

147

Date of diagnosis:148 __ __ __ __ - __ __- __ __

Bronchiolitis obliterans

Yes No

149

Date of diagnosis:150 __ __ __ __ - __ __- __ __

Cryptogenic organizing pneumonia

Yes No

151

(COP/BOOP)

Date of diagnosis:152 __ __ __ __ - __ __- __ __

Fibrosis

Yes No

153

Date of diagnosis:154 __ __ __ __ - __ __- __ __

Interstitial pneumonitis (IPn) / ARDS

Yes No

155

Date of diagnosis:156 __ __ __ __ - __ __- __ __

Pulmonary or diffuse alveolar hemorrhage

Yes No

157

Date of diagnosis:158 __ __ __ __ - __ __- __ __

Strictures (related to exposure)

Yes No

159

Date of diagnosis:160 __ __ __ __ - __ __- __ __

Wounds requiring surgery (related to exposure)

Yes No

161

Date of diagnosis:162 __ __ __ __ - __ __- __ __

Cataracts

Yes No

163

Date of diagnosis:164 __ __ __ __ - __ __- __ __

Other impairment or disorder

Yes No

165

Date of diagnosis:166 __ __ __ __ - __ __- __ __

Specify other impairment / disorder:167

New Malignancy Questions: 168 - 212

Did a new malignancy, myelodysplastic, or myeloproliferative disorder appear since the date of last report?

Yes No

168

Acute myeloid leukemia (AML / ANLL)

yes no

169

Date of diagnosis:170 __ __ __ __ - __ __- __ __

Other leukemia, including ALL

yes no

171

Date of diagnosis:172 __ __ __ __ - __ __- __ __

Specify other leukemia:173

Breast cancer

yes no

174

Date of diagnosis:175 __ __ __ __ - __ __- __ __

Central nervous system (CNS) malignancy

Yes No

176

(e.g. glioblastoma, astrocytoma)

Date of diagnosis:177 __ __ __ __ - __ __- __ __

Clonal cytogenetic abnormality without leukemia or MDS

Yes No

178

Date of diagnosis:179 __ __ __ __ - __ __- __ __

Gastrointestinal malignancy

Yes No

180

(e.g. colon, rectum, stomach, pancreas, intestine)

Date of diagnosis:181 __ __ __ __ - __ __- __ __

Genitourinary malignancy

Yes No

182

(e.g. kidney, bladder, ovary, testicle, genitalia, uterus, cervix)

Date of diagnosis:183 __ __ __ __ - __ __- __ __

Lung cancer

yes no

184

Date of diagnosis:185 __ __ __ __ - __ __- __ __

Hodgkin disease

yes no

186

Date of diagnosis:187 __ __ __ __ - __ __- __ __

Lymphoma or lymphoproliferative disease

Yes No

188

Date of diagnosis:189 __ __ __ __ - __ __- __ __

Was the tumor EBV positive?

yes no

190

Melanoma

Yes No

191

Date of diagnosis:192 __ __ __ __ - __ __- __ __

Basal cell skin malignancy

Yes No

193

Date of diagnosis:194 __ __ __ __ - __ __- __ __

Squamous cell skin malignancy

Yes No

195

Date of diagnosis:196 __ __ __ __ - __ __- __ __

Myelodysplastic syndrome (MDS)

yes no

197

Date of diagnosis:198 __ __ __ __ - __ __- __ __

Myeloproliferative neoplasm (MPN)

yes no

199

Date of diagnosis:200 __ __ __ __ - __ __- __ __

Myelodysplasia / myeloproliferative neoplasm

Yes No

201

Date of diagnosis:202 __ __ __ __ - __ __- __ __

Oropharyngeal cancer (e.g. tongue, buccal mucosa)

Yes No

203

Date of diagnosis:204 __ __ __ __ - __ __- __ __

Sarcoma

Yes No

205

Date of diagnosis:206 __ __ __ __ - __ __- __ __

Thyroid cancer

yes no

207

Date of diagnosis:208 __ __ __ __ - __ __- __ __

Other new malignancy

yes no

209

Date of diagnosis:210 __ __ __ __ - __ __- __ __

Specify other new malignancy:211

Was documentation submitted to the CIBMTR? (e.g. pathology/autopsy report or other documentation)

Yes No

212

Infection Questions: 213 - 219

Did the patient develop a clinically significant infection since the date of last report?

Yes No

213

Infection (1) Questions: 214 - 219

Organism:214

Specify other organism:215

Site:216

Site:217

Site:218

Date of diagnosis:219 __ __ __ __ - __ __- __ __

Therapy Questions: 220 - 258

Was therapy given since the date of last report?

yes no

220

Systemic antibacterial antibiotics

Yes No Unknown

221

Non-absorbable oral antibiotics

Yes No Unknown

222

Systemic antifungal drugs

Yes No Unknown

223

Amphotericin

Yes No

224

(Fungizone) (non-lipid formulation)

Amphotericin

Yes No

225

(e.g. Abelcet, AmBisome, Amphotec) (lipid formulation)

Caspofungin

Yes No

226

Fluconazole

Yes No

227

Isavuconazole

Yes No

228

Itraconazole

Yes No

229

Micafungin

Yes No

230

Posaconazole

Yes No

231

Ravuconazole

Yes No

232

Voriconazole

Yes No

233

Other systemic antifungal drug

Yes No

234

Specify other systemic antifungal drug:235

Antiviral drugs

Yes No Unknown

236

Acyclovir

yes no

237

Foscarnet

Yes No

238

Ganciclovir (DHPG)

yes no

239

Valganciclovir

Yes No

240

(Valcyte)

Valacyclovir

Yes No

241

Other antiviral drug

Yes No

242

Specify other antiviral drug:243

Growth factors

Yes No Unknown

244

G-CSF

yes no

245

GM-CSF

yes no

246

Pegylated G-CSF

yes no

247

TBO-filgrastim

Yes No

248

Other growth factor

yes no

249

Specify other growth factor:250

Corticosteroids

yes no

251

Erythropoietin

yes no

252

RBC transfusion

Yes No

253

Platelet transfusion

Yes No

254

HCT

Yes No

255

Cellular therapy

yes no

256

Other therapy

yes no

257

Specify other therapy:258

First Name: Last Name:

E-mail address: Date: __ __ __ __ - __ __- __ __

Specify the patient's functional status at last contact:

Provide the most recent value for each lab tested since the date of last report:

Report the most recent complete blood count:

Report the most recent lab values:

Other Organ Impairment/Disorder

Specify impairment/disorder:

Renal

Report highest values measured in this reporting period:

Report the lowest values measured in this reporting period:

Cardiac

Vascular

Central nervous system

Endocrine

Gastrointestinal

Genitourinary

Liver Toxicity

Musculoskeletal

Psychiatric

Pulmonary

Skin

Other

Specify which new disease(s) occurred:

Report each infection organism, site and date of diagnosis:

Do not report fever in the absence of infection.  Report the most specific site of infection. 

Specify therapy given for exposure or complications from exposure, since the date of last report:

Specify therapy given:

Center: CRID: 

Form 5001 R1.0: RITN Follow-Up Form

CIBMTR Form 5001 revision 1.0 last updated Monday, December 21, 2015
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 6 / 8



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Visit

100 day 6 months 1 year 2 years > 2 years

Specify:

Vital Status Questions: 1 - 9

Date of actual contact with the patient to determine the medical status for this follow-up report:1 __ __ __ __ - __ __- __ __

Specify the patient's survival status at the date of last contact

Alive Dead

2

Primary cause of death3

Specify:4

What scale was used to determine the patient’s functional status?

Karnofsky Lansky

5

Karnofsky scale (patient age ≥ 16 years)6

Lansky scale (patient age < 16 years)7

Has the patient become pregnant since the date of last report? (Female only)

Yes No Unknown

8

Has the patient fathered any children since the date of last report? (i.e. contributed to any pregnancies) (Male only)

Yes No Unknown

9

Organ Function Questions: 10 - 39

AST (SGOT)

Known Unknown

10

11 U/L µkat/L

Date sample collected:12 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:13 U/L µkat/L

ALT (SGPT)

Known Unknown

14

15 U/L µkat/L

Date sample collected:16 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:17 U/L µkat/L

Total serum bilirubin

Known Unknown

18

19 mg/dL µmol/L

Date sample collected:20 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:21 mg/dL µmol/L

Serum creatinine

Known Unknown

22

23 mg/dL mmol/L µmol/L

Date sample collected:24 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:25 mg/dL mmol/L µmol/L

Serum albumin

Known Unknown

26

27 g/dL g/L

Date sample collected:28 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:29 g/dL g/L

Amylase

Known Unknown

30

31 U/L

International normalized ratio (INR)

Known Unknown

32

(INR)

33

Partial thromboplastin time (PTT)

Known Unknown

34

35 seconds

Reticulocytes

Known Unknown

36

(uncorrected)

37
x 109/L

Was a bone marrow examination performed?

yes no Unknown

38

Date sample collected:39 __ __ __ __ - __ __- __ __

Complete Blood Count Questions: 40 - 56

Was a complete blood count done since the date of last report?

Yes No

40

Date sample collected:41 __ __ __ __ - __ __- __ __

WBC

Known Unknown

42

43 x 109/L (x 103/mm3)

x 106/L

Was G­CSF given ≤ 7 days before date of test?

Yes No

44

Neutrophils

Known Unknown

45

46 %

Lymphocytes

Known Unknown

47

48 %

Hemoglobin

Known Unknown

49

50 g/dL g/L mmol/L

Was RBC transfused < 30 days before date of test?

yes no

51

Hematocrit

Known Unknown

52

53 %

Platelets

Known Unknown

54

55 x 109/L (x 103/mm3)

x 106/L

Were platelets transfused ≤ 7 days before date of test?

Yes No

56

Lymphocyte Analyses Questions: 57 - 70

Were lymphocyte analyses performed?

yes no

57

Date sample collected:58 __ __ __ __ - __ __- __ __

CD3 (T cells)

Known Unknown

59

60 x 109/L (x 103/mm3)

x 106/L

CD4 (T helper cells)

Known Unknown

61

62 x 109/L (x 103/mm3)

x 106/L

CD8 (cytotoxic T cells)

Known Unknown

63

64 x 109/L (x 103/mm3)

x 106/L

CD19

Known Unknown

65

66 x 109/L (x 103/mm3)

x 106/L

CD20 (B lymphocyte cells)

Known Unknown

67

68 x 109/L (x 103/mm3)

x 106/L

CD56 (natural killer (NK) cells)

Known Unknown

69

70 x 109/L (x 103/mm3)

x 106/L

Organ Impairment / Disorders Questions: 71 - 167

Has the patient developed any clinically significant organ impairment or disorder since the date of the last report?

Yes No

71

Chronic kidney disease / renal impairment (persistent decrease in glomerular filtration rate to < 60 ml/min/1.73m2)

Yes No

72

Date of diagnosis:73 __ __ __ __ - __ __- __ __

Serum creatinine

Known Unknown

74

(peak in reporting period)

75 mg/dL mmol/L µmol/L

Date sample collected:76 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

77

(GFR) (calculated) (peak in reporting period)

78 mL/min/1.732

Date sample collected:79 __ __ __ __ - __ __- __ __

Was a renal biopsy performed?

Yes No Unknown

80

Serum creatinine

Known Unknown

81

(lowest in reporting period)

82 mg/dL mmol/L µmol/L

Date sample collected:83 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

84

(GFR) (calculated) (peak in reporting period)

85 mL/min/1.732

Date sample collected:86 __ __ __ __ - __ __- __ __

Hemorrhagic cystitis/hematuria

Yes No

87

Date of diagnosis:88 __ __ __ __ - __ __- __ __

Renal failure requiring dialysis

Yes No

89

Date dialysis started:90 __ __ __ __ - __ __- __ __

Arrhythmia

Yes No

91

(atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmia)

Date of diagnosis:92 __ __ __ __ - __ __- __ __

Congestive heart failure / Cardiomyopathy

Yes No

93

(EF < 40%)

Date of diagnosis:94 __ __ __ __ - __ __- __ __

Specify ejection fraction:95 %

Hypertension requiring therapy

Yes No

96

Date of diagnosis:97 __ __ __ __ - __ __- __ __

Myocardial infarction / Unstable angina

Yes No

98

Date of diagnosis:99 __ __ __ __ - __ __- __ __

Pericarditis

Yes No

100

Date of diagnosis:101 __ __ __ __ - __ __- __ __

Deep vein thrombosis (DVT) / Pulmonary embolism (PE)

Yes No

102

Date of diagnosis:103 __ __ __ __ - __ __- __ __

Was the DVT catheter related?

Yes No

104

Thrombotic microangiopathy

Yes No

105

(TMA)

Date of diagnosis:106 __ __ __ __ - __ __- __ __

CNS hemorrhage

Yes No

107

Date of diagnosis:108 __ __ __ __ - __ __- __ __

Encephalopathy

Yes No

109

(non-infectious)

Date of diagnosis:110 __ __ __ __ - __ __- __ __

Neuropathy

Yes No

111

Date of diagnosis:112 __ __ __ __ - __ __- __ __

Seizures

yes no

113

Date of diagnosis:114 __ __ __ __ - __ __- __ __

Stroke

Yes No

115

Date of diagnosis:116 __ __ __ __ - __ __- __ __

Transient ischemic attack

Yes No

117

(TIA)

Date of diagnosis:118 __ __ __ __ - __ __- __ __

Diabetes / hyperglycemia (requiring chronic treatment)

Yes No

119

Date of diagnosis:120 __ __ __ __ - __ __- __ __

Growth hormone deficiency / growth disturbance

Yes No

121

Date of diagnosis:122 __ __ __ __ - __ __- __ __

Hypothyroidism (requiring replacement therapy)

Yes No

123

Date of diagnosis:124 __ __ __ __ - __ __- __ __

Pancreatitis

Yes No

125

Date of diagnosis:126 __ __ __ __ - __ __- __ __

Diarrhea requiring therapy (requiring chronic treatment)

Yes No

127

Date of diagnosis:128 __ __ __ __ - __ __- __ __

Gastrointestinal (GI) bleeding

Yes No

129

Date of diagnosis:130 __ __ __ __ - __ __- __ __

Gonadal dysfunction / infertility requiring hormone replacement (testosterone or estrogen)

Yes No

131

Date of diagnosis:132 __ __ __ __ - __ __- __ __

Cirrhosis

Yes No

133

Date of diagnosis:134 __ __ __ __ - __ __- __ __

VOD

Yes No

135

Date of diagnosis:136 __ __ __ __ - __ __- __ __

Other non-infectious liver toxicity

Yes No

137

Date of diagnosis:138 __ __ __ __ - __ __- __ __

Avascular necrosis

Yes No

139

Date of diagnosis:140 __ __ __ __ - __ __- __ __

Osteoporosis

Yes No

141

Date of diagnosis:142 __ __ __ __ - __ __- __ __

Depression requiring therapy

Yes No

143

Date of diagnosis:144 __ __ __ __ - __ __- __ __

Anxiety requiring therapy

Yes No

145

Date of diagnosis:146 __ __ __ __ - __ __- __ __

Post-traumatic stress disorder (PTSD) requiring therapy

Yes No

147

Date of diagnosis:148 __ __ __ __ - __ __- __ __

Bronchiolitis obliterans

Yes No

149

Date of diagnosis:150 __ __ __ __ - __ __- __ __

Cryptogenic organizing pneumonia

Yes No

151

(COP/BOOP)

Date of diagnosis:152 __ __ __ __ - __ __- __ __

Fibrosis

Yes No

153

Date of diagnosis:154 __ __ __ __ - __ __- __ __

Interstitial pneumonitis (IPn) / ARDS

Yes No

155

Date of diagnosis:156 __ __ __ __ - __ __- __ __

Pulmonary or diffuse alveolar hemorrhage

Yes No

157

Date of diagnosis:158 __ __ __ __ - __ __- __ __

Strictures (related to exposure)

Yes No

159

Date of diagnosis:160 __ __ __ __ - __ __- __ __

Wounds requiring surgery (related to exposure)

Yes No

161

Date of diagnosis:162 __ __ __ __ - __ __- __ __

Cataracts

Yes No

163

Date of diagnosis:164 __ __ __ __ - __ __- __ __

Other impairment or disorder

Yes No

165

Date of diagnosis:166 __ __ __ __ - __ __- __ __

Specify other impairment / disorder:167

New Malignancy Questions: 168 - 212

Did a new malignancy, myelodysplastic, or myeloproliferative disorder appear since the date of last report?

Yes No

168

Acute myeloid leukemia (AML / ANLL)

yes no

169

Date of diagnosis:170 __ __ __ __ - __ __- __ __

Other leukemia, including ALL

yes no

171

Date of diagnosis:172 __ __ __ __ - __ __- __ __

Specify other leukemia:173

Breast cancer

yes no

174

Date of diagnosis:175 __ __ __ __ - __ __- __ __

Central nervous system (CNS) malignancy

Yes No

176

(e.g. glioblastoma, astrocytoma)

Date of diagnosis:177 __ __ __ __ - __ __- __ __

Clonal cytogenetic abnormality without leukemia or MDS

Yes No

178

Date of diagnosis:179 __ __ __ __ - __ __- __ __

Gastrointestinal malignancy

Yes No

180

(e.g. colon, rectum, stomach, pancreas, intestine)

Date of diagnosis:181 __ __ __ __ - __ __- __ __

Genitourinary malignancy

Yes No

182

(e.g. kidney, bladder, ovary, testicle, genitalia, uterus, cervix)

Date of diagnosis:183 __ __ __ __ - __ __- __ __

Lung cancer

yes no

184

Date of diagnosis:185 __ __ __ __ - __ __- __ __

Hodgkin disease

yes no

186

Date of diagnosis:187 __ __ __ __ - __ __- __ __

Lymphoma or lymphoproliferative disease

Yes No

188

Date of diagnosis:189 __ __ __ __ - __ __- __ __

Was the tumor EBV positive?

yes no

190

Melanoma

Yes No

191

Date of diagnosis:192 __ __ __ __ - __ __- __ __

Basal cell skin malignancy

Yes No

193

Date of diagnosis:194 __ __ __ __ - __ __- __ __

Squamous cell skin malignancy

Yes No

195

Date of diagnosis:196 __ __ __ __ - __ __- __ __

Myelodysplastic syndrome (MDS)

yes no

197

Date of diagnosis:198 __ __ __ __ - __ __- __ __

Myeloproliferative neoplasm (MPN)

yes no

199

Date of diagnosis:200 __ __ __ __ - __ __- __ __

Myelodysplasia / myeloproliferative neoplasm

Yes No

201

Date of diagnosis:202 __ __ __ __ - __ __- __ __

Oropharyngeal cancer (e.g. tongue, buccal mucosa)

Yes No

203

Date of diagnosis:204 __ __ __ __ - __ __- __ __

Sarcoma

Yes No

205

Date of diagnosis:206 __ __ __ __ - __ __- __ __

Thyroid cancer

yes no

207

Date of diagnosis:208 __ __ __ __ - __ __- __ __

Other new malignancy

yes no

209

Date of diagnosis:210 __ __ __ __ - __ __- __ __

Specify other new malignancy:211

Was documentation submitted to the CIBMTR? (e.g. pathology/autopsy report or other documentation)

Yes No

212

Infection Questions: 213 - 219

Did the patient develop a clinically significant infection since the date of last report?

Yes No

213

Infection (1) Questions: 214 - 219

Organism:214

Specify other organism:215

Site:216

Site:217

Site:218

Date of diagnosis:219 __ __ __ __ - __ __- __ __

Therapy Questions: 220 - 258

Was therapy given since the date of last report?

yes no

220

Systemic antibacterial antibiotics

Yes No Unknown

221

Non-absorbable oral antibiotics

Yes No Unknown

222

Systemic antifungal drugs

Yes No Unknown

223

Amphotericin

Yes No

224

(Fungizone) (non-lipid formulation)

Amphotericin

Yes No

225

(e.g. Abelcet, AmBisome, Amphotec) (lipid formulation)

Caspofungin

Yes No

226

Fluconazole

Yes No

227

Isavuconazole

Yes No

228

Itraconazole

Yes No

229

Micafungin

Yes No

230

Posaconazole

Yes No

231

Ravuconazole

Yes No

232

Voriconazole

Yes No

233

Other systemic antifungal drug

Yes No

234

Specify other systemic antifungal drug:235

Antiviral drugs

Yes No Unknown

236

Acyclovir

yes no

237

Foscarnet

Yes No

238

Ganciclovir (DHPG)

yes no

239

Valganciclovir

Yes No

240

(Valcyte)

Valacyclovir

Yes No

241

Other antiviral drug

Yes No

242

Specify other antiviral drug:243

Growth factors

Yes No Unknown

244

G-CSF

yes no

245

GM-CSF

yes no

246

Pegylated G-CSF

yes no

247

TBO-filgrastim

Yes No

248

Other growth factor

yes no

249

Specify other growth factor:250

Corticosteroids

yes no

251

Erythropoietin

yes no

252

RBC transfusion

Yes No

253

Platelet transfusion

Yes No

254

HCT

Yes No

255

Cellular therapy

yes no

256

Other therapy

yes no

257

Specify other therapy:258

First Name: Last Name:

E-mail address: Date: __ __ __ __ - __ __- __ __

Specify the patient's functional status at last contact:

Provide the most recent value for each lab tested since the date of last report:

Report the most recent complete blood count:

Report the most recent lab values:

Other Organ Impairment/Disorder

Specify impairment/disorder:

Renal

Report highest values measured in this reporting period:

Report the lowest values measured in this reporting period:

Cardiac

Vascular

Central nervous system

Endocrine

Gastrointestinal

Genitourinary

Liver Toxicity

Musculoskeletal

Psychiatric

Pulmonary

Skin

Other

Specify which new disease(s) occurred:

Report each infection organism, site and date of diagnosis:

Do not report fever in the absence of infection.  Report the most specific site of infection. 

Specify therapy given for exposure or complications from exposure, since the date of last report:

Specify therapy given:

Center: CRID: 

Form 5001 R1.0: RITN Follow-Up Form

CIBMTR Form 5001 revision 1.0 last updated Monday, December 21, 2015
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 7 / 8



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Visit

100 day 6 months 1 year 2 years > 2 years

Specify:

Vital Status Questions: 1 - 9

Date of actual contact with the patient to determine the medical status for this follow-up report:1 __ __ __ __ - __ __- __ __

Specify the patient's survival status at the date of last contact

Alive Dead

2

Primary cause of death3

Specify:4

What scale was used to determine the patient’s functional status?

Karnofsky Lansky

5

Karnofsky scale (patient age ≥ 16 years)6

Lansky scale (patient age < 16 years)7

Has the patient become pregnant since the date of last report? (Female only)

Yes No Unknown

8

Has the patient fathered any children since the date of last report? (i.e. contributed to any pregnancies) (Male only)

Yes No Unknown

9

Organ Function Questions: 10 - 39

AST (SGOT)

Known Unknown

10

11 U/L µkat/L

Date sample collected:12 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:13 U/L µkat/L

ALT (SGPT)

Known Unknown

14

15 U/L µkat/L

Date sample collected:16 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:17 U/L µkat/L

Total serum bilirubin

Known Unknown

18

19 mg/dL µmol/L

Date sample collected:20 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:21 mg/dL µmol/L

Serum creatinine

Known Unknown

22

23 mg/dL mmol/L µmol/L

Date sample collected:24 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:25 mg/dL mmol/L µmol/L

Serum albumin

Known Unknown

26

27 g/dL g/L

Date sample collected:28 __ __ __ __ - __ __- __ __

Upper limit of normal for your institution:29 g/dL g/L

Amylase

Known Unknown

30

31 U/L

International normalized ratio (INR)

Known Unknown

32

(INR)

33

Partial thromboplastin time (PTT)

Known Unknown

34

35 seconds

Reticulocytes

Known Unknown

36

(uncorrected)

37
x 109/L

Was a bone marrow examination performed?

yes no Unknown

38

Date sample collected:39 __ __ __ __ - __ __- __ __

Complete Blood Count Questions: 40 - 56

Was a complete blood count done since the date of last report?

Yes No

40

Date sample collected:41 __ __ __ __ - __ __- __ __

WBC

Known Unknown

42

43 x 109/L (x 103/mm3)

x 106/L

Was G­CSF given ≤ 7 days before date of test?

Yes No

44

Neutrophils

Known Unknown

45

46 %

Lymphocytes

Known Unknown

47

48 %

Hemoglobin

Known Unknown

49

50 g/dL g/L mmol/L

Was RBC transfused < 30 days before date of test?

yes no

51

Hematocrit

Known Unknown

52

53 %

Platelets

Known Unknown

54

55 x 109/L (x 103/mm3)

x 106/L

Were platelets transfused ≤ 7 days before date of test?

Yes No

56

Lymphocyte Analyses Questions: 57 - 70

Were lymphocyte analyses performed?

yes no

57

Date sample collected:58 __ __ __ __ - __ __- __ __

CD3 (T cells)

Known Unknown

59

60 x 109/L (x 103/mm3)

x 106/L

CD4 (T helper cells)

Known Unknown

61

62 x 109/L (x 103/mm3)

x 106/L

CD8 (cytotoxic T cells)

Known Unknown

63

64 x 109/L (x 103/mm3)

x 106/L

CD19

Known Unknown

65

66 x 109/L (x 103/mm3)

x 106/L

CD20 (B lymphocyte cells)

Known Unknown

67

68 x 109/L (x 103/mm3)

x 106/L

CD56 (natural killer (NK) cells)

Known Unknown

69

70 x 109/L (x 103/mm3)

x 106/L

Organ Impairment / Disorders Questions: 71 - 167

Has the patient developed any clinically significant organ impairment or disorder since the date of the last report?

Yes No

71

Chronic kidney disease / renal impairment (persistent decrease in glomerular filtration rate to < 60 ml/min/1.73m2)

Yes No

72

Date of diagnosis:73 __ __ __ __ - __ __- __ __

Serum creatinine

Known Unknown

74

(peak in reporting period)

75 mg/dL mmol/L µmol/L

Date sample collected:76 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

77

(GFR) (calculated) (peak in reporting period)

78 mL/min/1.732

Date sample collected:79 __ __ __ __ - __ __- __ __

Was a renal biopsy performed?

Yes No Unknown

80

Serum creatinine

Known Unknown

81

(lowest in reporting period)

82 mg/dL mmol/L µmol/L

Date sample collected:83 __ __ __ __ - __ __- __ __

Glomerular filtration rate

Known Unknown

84

(GFR) (calculated) (peak in reporting period)

85 mL/min/1.732

Date sample collected:86 __ __ __ __ - __ __- __ __

Hemorrhagic cystitis/hematuria

Yes No

87

Date of diagnosis:88 __ __ __ __ - __ __- __ __

Renal failure requiring dialysis

Yes No

89

Date dialysis started:90 __ __ __ __ - __ __- __ __

Arrhythmia

Yes No

91

(atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmia)

Date of diagnosis:92 __ __ __ __ - __ __- __ __

Congestive heart failure / Cardiomyopathy

Yes No

93

(EF < 40%)

Date of diagnosis:94 __ __ __ __ - __ __- __ __

Specify ejection fraction:95 %

Hypertension requiring therapy

Yes No

96

Date of diagnosis:97 __ __ __ __ - __ __- __ __

Myocardial infarction / Unstable angina

Yes No

98

Date of diagnosis:99 __ __ __ __ - __ __- __ __

Pericarditis

Yes No

100

Date of diagnosis:101 __ __ __ __ - __ __- __ __

Deep vein thrombosis (DVT) / Pulmonary embolism (PE)

Yes No

102

Date of diagnosis:103 __ __ __ __ - __ __- __ __

Was the DVT catheter related?

Yes No

104

Thrombotic microangiopathy

Yes No

105

(TMA)

Date of diagnosis:106 __ __ __ __ - __ __- __ __

CNS hemorrhage

Yes No

107

Date of diagnosis:108 __ __ __ __ - __ __- __ __

Encephalopathy

Yes No

109

(non-infectious)

Date of diagnosis:110 __ __ __ __ - __ __- __ __

Neuropathy

Yes No

111

Date of diagnosis:112 __ __ __ __ - __ __- __ __

Seizures

yes no

113

Date of diagnosis:114 __ __ __ __ - __ __- __ __

Stroke

Yes No

115

Date of diagnosis:116 __ __ __ __ - __ __- __ __

Transient ischemic attack

Yes No

117

(TIA)

Date of diagnosis:118 __ __ __ __ - __ __- __ __

Diabetes / hyperglycemia (requiring chronic treatment)

Yes No

119

Date of diagnosis:120 __ __ __ __ - __ __- __ __

Growth hormone deficiency / growth disturbance

Yes No

121

Date of diagnosis:122 __ __ __ __ - __ __- __ __

Hypothyroidism (requiring replacement therapy)

Yes No

123

Date of diagnosis:124 __ __ __ __ - __ __- __ __

Pancreatitis

Yes No

125

Date of diagnosis:126 __ __ __ __ - __ __- __ __

Diarrhea requiring therapy (requiring chronic treatment)

Yes No

127

Date of diagnosis:128 __ __ __ __ - __ __- __ __

Gastrointestinal (GI) bleeding

Yes No

129

Date of diagnosis:130 __ __ __ __ - __ __- __ __

Gonadal dysfunction / infertility requiring hormone replacement (testosterone or estrogen)

Yes No

131

Date of diagnosis:132 __ __ __ __ - __ __- __ __

Cirrhosis

Yes No

133

Date of diagnosis:134 __ __ __ __ - __ __- __ __

VOD

Yes No

135

Date of diagnosis:136 __ __ __ __ - __ __- __ __

Other non-infectious liver toxicity

Yes No

137

Date of diagnosis:138 __ __ __ __ - __ __- __ __

Avascular necrosis

Yes No

139

Date of diagnosis:140 __ __ __ __ - __ __- __ __

Osteoporosis

Yes No

141

Date of diagnosis:142 __ __ __ __ - __ __- __ __

Depression requiring therapy

Yes No

143

Date of diagnosis:144 __ __ __ __ - __ __- __ __

Anxiety requiring therapy

Yes No

145

Date of diagnosis:146 __ __ __ __ - __ __- __ __

Post-traumatic stress disorder (PTSD) requiring therapy

Yes No

147

Date of diagnosis:148 __ __ __ __ - __ __- __ __

Bronchiolitis obliterans

Yes No

149

Date of diagnosis:150 __ __ __ __ - __ __- __ __

Cryptogenic organizing pneumonia

Yes No

151

(COP/BOOP)

Date of diagnosis:152 __ __ __ __ - __ __- __ __

Fibrosis

Yes No

153

Date of diagnosis:154 __ __ __ __ - __ __- __ __

Interstitial pneumonitis (IPn) / ARDS

Yes No

155

Date of diagnosis:156 __ __ __ __ - __ __- __ __

Pulmonary or diffuse alveolar hemorrhage

Yes No

157

Date of diagnosis:158 __ __ __ __ - __ __- __ __

Strictures (related to exposure)

Yes No

159

Date of diagnosis:160 __ __ __ __ - __ __- __ __

Wounds requiring surgery (related to exposure)

Yes No

161

Date of diagnosis:162 __ __ __ __ - __ __- __ __

Cataracts

Yes No

163

Date of diagnosis:164 __ __ __ __ - __ __- __ __

Other impairment or disorder

Yes No

165

Date of diagnosis:166 __ __ __ __ - __ __- __ __

Specify other impairment / disorder:167

New Malignancy Questions: 168 - 212

Did a new malignancy, myelodysplastic, or myeloproliferative disorder appear since the date of last report?

Yes No

168

Acute myeloid leukemia (AML / ANLL)

yes no

169

Date of diagnosis:170 __ __ __ __ - __ __- __ __

Other leukemia, including ALL

yes no

171

Date of diagnosis:172 __ __ __ __ - __ __- __ __

Specify other leukemia:173

Breast cancer

yes no

174

Date of diagnosis:175 __ __ __ __ - __ __- __ __

Central nervous system (CNS) malignancy

Yes No

176

(e.g. glioblastoma, astrocytoma)

Date of diagnosis:177 __ __ __ __ - __ __- __ __

Clonal cytogenetic abnormality without leukemia or MDS

Yes No

178

Date of diagnosis:179 __ __ __ __ - __ __- __ __

Gastrointestinal malignancy

Yes No

180

(e.g. colon, rectum, stomach, pancreas, intestine)

Date of diagnosis:181 __ __ __ __ - __ __- __ __

Genitourinary malignancy

Yes No

182

(e.g. kidney, bladder, ovary, testicle, genitalia, uterus, cervix)

Date of diagnosis:183 __ __ __ __ - __ __- __ __

Lung cancer

yes no

184

Date of diagnosis:185 __ __ __ __ - __ __- __ __

Hodgkin disease

yes no

186

Date of diagnosis:187 __ __ __ __ - __ __- __ __

Lymphoma or lymphoproliferative disease

Yes No

188

Date of diagnosis:189 __ __ __ __ - __ __- __ __

Was the tumor EBV positive?

yes no

190

Melanoma

Yes No

191

Date of diagnosis:192 __ __ __ __ - __ __- __ __

Basal cell skin malignancy

Yes No

193

Date of diagnosis:194 __ __ __ __ - __ __- __ __

Squamous cell skin malignancy

Yes No

195

Date of diagnosis:196 __ __ __ __ - __ __- __ __

Myelodysplastic syndrome (MDS)

yes no

197

Date of diagnosis:198 __ __ __ __ - __ __- __ __

Myeloproliferative neoplasm (MPN)

yes no

199

Date of diagnosis:200 __ __ __ __ - __ __- __ __

Myelodysplasia / myeloproliferative neoplasm

Yes No

201

Date of diagnosis:202 __ __ __ __ - __ __- __ __

Oropharyngeal cancer (e.g. tongue, buccal mucosa)

Yes No

203

Date of diagnosis:204 __ __ __ __ - __ __- __ __

Sarcoma

Yes No

205

Date of diagnosis:206 __ __ __ __ - __ __- __ __

Thyroid cancer

yes no

207

Date of diagnosis:208 __ __ __ __ - __ __- __ __

Other new malignancy

yes no

209

Date of diagnosis:210 __ __ __ __ - __ __- __ __

Specify other new malignancy:211

Was documentation submitted to the CIBMTR? (e.g. pathology/autopsy report or other documentation)

Yes No

212

Infection Questions: 213 - 219

Did the patient develop a clinically significant infection since the date of last report?

Yes No

213

Infection (1) Questions: 214 - 219

Organism:214

Specify other organism:215

Site:216

Site:217

Site:218

Date of diagnosis:219 __ __ __ __ - __ __- __ __

Therapy Questions: 220 - 258

Was therapy given since the date of last report?

yes no

220

Systemic antibacterial antibiotics

Yes No Unknown

221

Non-absorbable oral antibiotics

Yes No Unknown

222

Systemic antifungal drugs

Yes No Unknown

223

Amphotericin

Yes No

224

(Fungizone) (non-lipid formulation)

Amphotericin

Yes No

225

(e.g. Abelcet, AmBisome, Amphotec) (lipid formulation)

Caspofungin

Yes No

226

Fluconazole

Yes No

227

Isavuconazole

Yes No

228

Itraconazole

Yes No

229

Micafungin

Yes No

230

Posaconazole

Yes No

231

Ravuconazole

Yes No

232

Voriconazole

Yes No

233

Other systemic antifungal drug

Yes No

234

Specify other systemic antifungal drug:235

Antiviral drugs

Yes No Unknown

236

Acyclovir

yes no

237

Foscarnet

Yes No

238

Ganciclovir (DHPG)

yes no

239

Valganciclovir

Yes No

240

(Valcyte)

Valacyclovir

Yes No

241

Other antiviral drug

Yes No

242

Specify other antiviral drug:243

Growth factors

Yes No Unknown

244

G-CSF

yes no

245

GM-CSF

yes no

246

Pegylated G-CSF

yes no

247

TBO-filgrastim

Yes No

248

Other growth factor

yes no

249

Specify other growth factor:250

Corticosteroids

yes no

251

Erythropoietin

yes no

252

RBC transfusion

Yes No

253

Platelet transfusion

Yes No

254

HCT

Yes No

255

Cellular therapy

yes no

256

Other therapy

yes no

257

Specify other therapy:258

First Name: Last Name:

E-mail address: Date: __ __ __ __ - __ __- __ __

Specify the patient's functional status at last contact:

Provide the most recent value for each lab tested since the date of last report:

Report the most recent complete blood count:

Report the most recent lab values:

Other Organ Impairment/Disorder

Specify impairment/disorder:

Renal

Report highest values measured in this reporting period:

Report the lowest values measured in this reporting period:

Cardiac

Vascular

Central nervous system

Endocrine

Gastrointestinal

Genitourinary

Liver Toxicity

Musculoskeletal

Psychiatric

Pulmonary

Skin

Other

Specify which new disease(s) occurred:

Report each infection organism, site and date of diagnosis:

Do not report fever in the absence of infection.  Report the most specific site of infection. 

Specify therapy given for exposure or complications from exposure, since the date of last report:

Specify therapy given:

Center: CRID: 

Form 5001 R1.0: RITN Follow-Up Form

CIBMTR Form 5001 revision 1.0 last updated Monday, December 21, 2015
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 8 / 8